===== DISCHARGE NOTE =====
note_id=15521468-DS-15 | hadm_id=20145957

 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Bactrim
 
Attending: ___.
 
Chief Complaint:
Chest pain
 
Major Surgical or Invasive Procedure:
Cardiac cath

 
History of Present Illness:
___ with PMH of CABG (5 grafts) in ___, PCI x 4, DM, HTN p/w 
chest pain x 5 days. Patient's chest pain began on ___, 
originated in her back, and was associated with substernal chest 
pressure. These episodes were not associated with nausea, 
diaphoresis, palpatations, radiation to arms, or exertion. 
However, they are similar to her previous presentation prior to 
her CABG.  
.  
In the ED, her vitals were 101/52 61 96% RA. An EKG was 
performed which showed no acute changes. She was given ASA, SL 
NTG x 3 and 8 mg IV morphine with improvement in her chest pain. 
A heparin gtt was not started. A chest CTA was also performed to 
rule out PE and dissection and was negative.  
.  
ROS was negative for F/C/abdominal pain.  

 
Past Medical History:
PAST MEDICAL HISTORY:  ___ has got a number of medical 
problems stemming from hypertension and diabetes.  She has had 
diabetes for a long period of time and her most recent 
hemoglobin A1c level was notably elevated at 14%.  She has a 
history of coronary artery disease and had a CABG in ___.  She 
reportedly has an ejection fraction of 50 to 55%.  She has a 
history of hyperlipidemia and hypertension.  With respect to her 
bypass, she has had stents placed as well.  Her CABG was 
complicated by a sternal wound infection.  Her most recent echo 
was obtained on ___.  This reveals ejection fraction of 
greater than or equal to 55% with no evidence of endocarditis.  
She has never had a colonoscopy and she had her last mammogram 
___ years ago. She also has anemia and her most recent 
hematocrit was 30%.  She has an elevated platelet level greater 
than 500.
.
PAST SURGICAL HISTORY:  In ___ and ___, she had her coronary
artery bypass.  She has had three C-sections.
.
OB/GYN HISTORY:  She denies any history of pelvic infections. 
She denies any history of abnormal Pap smears, and her last was
obtained in ___.  She denies any complications of cesarean
section.
 
Social History:
___
Family History:
She reports her mother developed lung cancer, she was a smoker.  
She had a grandmother and an aunt who had breast cancer, 
grandmother was sick in her ___ and her aunt was in her ___.  
There is no other family history of cancer.
 
Physical Exam:
Vitals: Tc 97.2 HR 58 BP 138/76 RR  
General: Alert and oriented x 3, NAD  
HEENT: ATNC, EOMI  
Neck: supple, no significant JVD or carotid bruits  
Pulmonary: CTAB, no wheezes, rales, or rhonchi  
Cardiac: RRR, nl S1 S2, ___ HS murmur, rubs, or gallops  
Abdomen: soft, NT, ND, normoactive bowel sounds, no masses or 
organomegaly  
Extremities: mild edema, 2+ ___ pulses b/l  
Lymphatics: No cervical, supraclavicular, axillary or inguinal 
lymphadenopathy noted  
Skin: no echymoses  

 
Pertinent Results:
___ 10:00PM   PTT-36.8*
___ 05:00PM   CK-MB-NotDone cTropnT-<0.01
___ 05:00PM   CK-MB-NotDone cTropnT-<0.01
___ 05:00PM   ___ PTT-25.7 ___
___ 07:50AM   GLUCOSE-355* UREA N-16 CREAT-0.7 SODIUM-135 
POTASSIUM-5.0 CHLORIDE-100 TOTAL CO2-28 ANION GAP-12
___ 07:50AM   estGFR-Using this
___ 07:50AM   CK(CPK)-76
___ 07:50AM   cTropnT-<0.01
___ 07:50AM   CK-MB-NotDone
___ 07:50AM   %HbA1c-10.9___ 07:50AM   NEUTS-54.1 ___ MONOS-4.3 EOS-2.6 
BASOS-1.0
___ 07:50AM   NEUTS-54.1 ___ MONOS-4.3 EOS-2.6 
BASOS-1.0
___ 07:50AM   PLT COUNT-341

CARDIAC CATH:
COMMENTS:      
1. Coronary angiography in this right dominant system revealed 
two 
vessel coronary artery disease. The LMCA had no significant 
disease. The 
LAD was totally occluded at the mid segment. The OM1 stent was 
known 
occluded. The distal LCxs stent was occluded at its distal edge. 
The 
distal OM beyond the stent filled by R>L collaterals. 
2. Arterial conduit angiography revealed the LIMA to be widely 
patent. 
The SVGs were not engaged as known to be occluded. 
3. Successful PTCA of the distal LCX stent with a 2.0x15 Voyager 
balloon 
and a 2.25x15mm Quantum Maverick balloon. Final angiography 
revealed no 
residual stenosis, no angiographically apparent dissection and 
TIMI III 
flow (see ___ comments). 
  
FINAL DIAGNOSIS:     
1. Two vessel coronary artery disease. 
2. Patent LIMA to LAD. 
3. Successful PTCA Of the LCX. 

 
Brief Hospital Course:
___ with history of CAD s/p CABG and PCI, DM, HTN p/w 
CP.  
  
## Chest pain: Patient's chest pain complaints were more 
consistent with MSK pain than cardiac ischemia.  Her cardiac 
enzymes were negative but given her significant cardiac history, 
she was taken to cardiac catheterization.  There, she was found 
to have total occlusion of her left circumflex and PTCA was 
performed, with successful dilation of the artery.  No stent was 
placed.  She was discharged on a BB, statin, ASA, and 
clopidogrel, all of which she was already taking at the time of 
admission.  

## Diabetes mellitus: Patient has insulin dependent diabetes and 
her HbA1C was 10% at time of admission, suggesting poor glucose 
control.  This is her most significant cardiac risk factor that 
is not currently medically managed optimally.  She states that 
she is adherent to her medications and she was advised to 
continue to follow her blood glucose levels closely at home.  
During her admission, her finger stick glucose levels were well 
controlled.
  

 
Medications on Admission:
Medications on admission:  
1. Amlodipine 10 mg  
2. Metoprolol Tartrate 100 mg  
3. Furosemide 40 mg bid  
4. Gabapentin 300 mg Capsule Sig: One (1) Capsule PO Q8H (every  

8 hours).  
5. Nitroglycerin 0.3 mg Tablet, Sublingual Sig: One (1) Tablet,  

Sublingual Sublingual PRN (as needed) as needed for chest pain.  

6. Insulin Glargine Subcutaneous  
7. Ibuprofen 800 mg Tablet Sig: One (1) Tablet PO every six (6)  

hours as needed for pain. Disp:*30 Tablet(s)* Refills:*0*  
8. Colace 100 mg Capsule Sig: One (1) Capsule PO twice a day.  
9. Insulin sliding scale (60u glargine QHS)  
10. Aspirin 325 mg  
11. Atorvastatin 80 mg  
12. Clopidogrel 75 mg  
13. Niaspan *NF* 750 mg  

 
Discharge Medications:
1. Aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  
2. Atorvastatin 80 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
3. Isosorbide Mononitrate 30 mg Tablet Sustained Release 24 hr 
Sig: One (1) Tablet Sustained Release 24 hr PO DAILY (Daily).  
4. Furosemide 40 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day).  
5. Metoprolol Tartrate 50 mg Tablet Sig: Two (2) Tablet PO BID 
(2 times a day).  
6. Gabapentin 300 mg Capsule Sig: One (1) Capsule PO TID (3 
times a day).  
7. Niacin 250 mg Capsule, Sustained Release Sig: Three (3) 
Capsule, Sustained Release PO qhs ().  
8. Nitroglycerin 0.3 mg Tablet, Sublingual Sig: ___ Tablet, 
Sublinguals Sublingual PRN (as needed).  
9. Amlodipine 5 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).  

10. Clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
11. Hydrocodone-Acetaminophen ___ mg Tablet Sig: ___ Tablets 
PO Q4H (every 4 hours) as needed for pain.
Disp:*20 Tablet(s)* Refills:*0*
12. Ibuprofen 600 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 
hours) for 4 days.
Disp:*16 Tablet(s)* Refills:*0*
13. Ergocalciferol (Vitamin D2) 50,000 unit Capsule Sig: One (1) 
Capsule PO QWK ().  
14. Insulin Glargine  Subcutaneous

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary:
Coronary artery disease
.
Secondary:
Hypertension
Diabetes
Dyslipidemia

 
Discharge Condition:
Stable

 
Discharge Instructions:
You were admitted because of chest pain.  We determined that you 
were not having a heart attack.  However, we found a blockage of 
one of your coronary arteries and relieved this blockage by 
dilating the artery.
.
Please take all of your medications as prescribed.  We did not 
change any of your medications.  We gave you a few days of pain 
pills to help with your chest pain. Please keep all of your 
follow-up appointments.
.
Please call your doctor or return to the hospital if you 
experience fevers, chills, sweats, chest pain, shortness of 
breath or anything else of concern.

 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=15521468-DS-25 | hadm_id=20291206

 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
Bactrim / Nafcillin / Lisinopril / difficult intubation requires 
LMA
 
Attending: ___.
 
Chief Complaint:
Gangrene R ___ finger 
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ h/o CAD s/p CABG x4, multiple cardiac stents, ESRD on PD, 
DM2, LLE osteomyelitis and gangrene of multiple digits of the 
right hand s/p right R ___ finger amputation on ___ and R 
___ finger amputation on ___ now presenting with painful 
right ___ digit. 

According to the patient she had no hand problems until 
approximately 2 months ago, when she noted intermittent episodes 
of discoloration (initially red, later purple) of R ring and 
middle fingers; she states this was not exacerbated by cold, but 
she does endorse cold sensitivity in her hands. Painful blisters 
subsequently developed on finger tips of R hand, followed by 
necrosis, and she therefore underwent two recent figner 
amputations by Dr. ___: R ring finger MCP amputation 
on ___ and R middle finger MCP amputation on ___. 
However, painful blistering then developed over R index finger, 
as well as over L index, middle, and ring fingers within the 
last 2 weeks. She also reports progressive dehiscence of the 
amputation site of the R middle finger, with purulent drainage 
x2 weeks. She was admitted directly from Dr. ___ 
on ___ under Dr. ___ a possible amputation of the 
gangrenous finger.

 
Past Medical History:
PMH: CAD s/p CABG and multiple cath/stents, DM2 c/b retinopathy 
and neuropathy, HTN, HL, dCHF, ESRD on PD, obesity, LLE charcot 
ankle c/b osteomyelitis ___ s/p debridement, dieulafoy's lesion 
c/b massive GI bleed

PSH: CABG x5v ___, PD catheter placement 

 
Social History:
___
Family History:
significant for CAD
 
Physical Exam:
PHYSICAL EXAM ON ADMISSION

Vital Signs: Temp: 98.3 RR: 18 Pulse: 76 BP: 126/70  
Neuro/Psych: Oriented x3, Affect Normal, NAD. 
Neck: No masses, Trachea midline. 
Nodes: No clavicular/cervical adenopathy. 
Skin: No atypical lesions. 
Heart: Regular rate and rhythm. 
Lungs: Clear. 
Gastrointestinal: Non distended, No masses, Guarding or rebound. 

Rectal: Not Examined. 
Extremeties: 
 - RUE Radial: D. Ulnar: D. 
 - LUE Radial: D. Ulnar: D. 
 - RLE Femoral: P. Popiteal: D. DP: D. ___: D. 
 - LLE Femoral: P. Popiteal: D. DP: D. ___: D. 
Wounds: 
 - Side: Bilateral. RUE: ___ digit amp site is ealing well with
   sutures in place, ___ digit amp site shows some dehiscence 
and some   serosanguinous discharge, ___ digit black, necrotic 
at distal tip
 - LUE: ___ digit black and necrotic at distal tip

PHYSICAL EXAM ON DISCHARGE

Neuro/Psych: Oriented x3, Affect Normal, NAD. 
Neck: No masses, Trachea midline. 
Nodes: No clavicular/cervical adenopathy. 
Skin: No atypical lesions. 
Heart: Regular rate and rhythm. 
Lungs: Clear. 
Gastrointestinal: Non distended, No masses, Guarding or rebound. 

Rectal: Not Examined. 
Extremeties: 
 - RUE Radial: D. Ulnar: D. 
 - LUE Radial: D. Ulnar: D. 
 - RLE Femoral: P. Popiteal: D. DP: D. ___: D. 
 - LLE Femoral: P. Popiteal: D. DP: D. ___: D. 
Wounds: 
 - Side: Bilateral. RUE: ___ digit amp site is Healing well with
   sutures in place, ___ digit amp site is clean, ___ digit 
black, necrotic at distal tip
 - LUE: ___ digit black and necrotic at distal tip

 
Pertinent Results:
___ 08:20AM BLOOD WBC-11.5* RBC-2.77* Hgb-7.8* Hct-25.2* 
MCV-91 MCH-28.1 MCHC-30.9* RDW-16.5* Plt ___
___ 06:40AM BLOOD ___ PTT-35.0 ___
___ 03:45PM BLOOD Thrombn-14.5
___ 03:45PM BLOOD ESR-135*
___ 03:45PM BLOOD Lupus-POS ACA IgG-4.2 ACA IgM-6.8
___ 06:40AM BLOOD Glucose-117* UreaN-30* Creat-6.1* Na-142 
K-3.5 Cl-86* HCO3-16* AnGap-44*
___ 06:40AM BLOOD Calcium-10.3 Phos-5.6* Mg-1.8
___ 09:10AM BLOOD VitB12-951*
___ 03:10PM BLOOD PTH-239*
___ 12:45PM BLOOD HBsAg-NEGATIVE HBsAb-NEGATIVE 
HBcAb-NEGATIVE
___ 12:45PM BLOOD ANCA-NEGATIVE B
___ 03:45PM BLOOD ___
___ 03:45PM BLOOD CRP-49.4*
___ 12:45PM BLOOD HCV Ab-NEGATIVE
___ 03:45PM BLOOD BETA-2-GLYCOPROTEIN 1 ANTIBODIES (IGA, 
IGM, IGG)-Test      
 
Brief Hospital Course:
The patient presented as above and was admitted under Dr. 
___. She was started on broad-spectrum IV antibiotics 
and pain control. Her Coumadin was held and she was started on a 
heparin drip. Nephrology and ___ were taken on board to 
manage the patient's dialysis and diabetes respectively. Hand 
surgery was consulted who decided against surgical intervention 
given the absence of infection, cellulitis, and other clinical 
indications for immediate debridement or amputation. 
Additonally, given that the patient's primary complaint was 
diffuse, L > R hand pain, the primary areas of pain were though 
to be outside the areas of critical ischemia. Their impression 
was that amputation of the gangrenous/necrotic tissue would 
likely not effectively treat the patient's pain. 

Nest, rhematology was taken on board to help with diagnosis. 
They recommended holding midodrine (as it could be decreasing 
perfusion to the patient's fingers) and hypercoagulation workup 
which was sent. The work up has been largely non-revealing. 
Although lupus anticoagulant was positive it was thought that 
that could very well be a false positive result given the 
patient's home use of Warfarin.

Per Dr. ___ and his past experiences, the 
patient was started on empiric treatment for calciphylaxis with 
IV sodium thiosulphate. Efforts were made to get a tissue 
diagnosis by asking renal pathology to look at old slides from 
gross amputation samples but the slides were not obtainable. A 
new biopsy had the risk of non-healing so was not attempted. 

Over the course of this hospital stay the patient's symptoms 
have improved. Her pain is currently well-controled on PO meds 
and her tissue deterioration seems to have stabilized. The 
patient agrees that her current management has helped her. The 
plan for now is for her to continue receiving sodium 
thiosulphate on outpatient basis through her paritoneal 
dialysate (her primary nephrologist Dr. ___ has been 
contacted and has agreed to coordinate this). She will maintain 
close follow-up with Vascular Surgery (Drs. ___ 
who will reassess the need for surgical intervention depending 
on how the patient does on medical management.

The patient is being discharged today for home with services on 
PO antibiotics for two weeks and all her home meds except for 
midodrine and warfarin. She will follow up with Dr ___ 
___ in the next ___ weeks with a repeat testing of lupus 
anti-coagulant and with Dr ___ Rheumatology in three 
months.

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Nystatin Cream 1 Appl TP BID Fungal infection 
Please apply on the patient's buttocks, thighs, stomach and 
under both breasts. 
2. Omeprazole 40 mg PO DAILY 
3. Gabapentin 100 mg PO BID 
4. Midodrine 10 mg PO BID 
5. Nitroglycerin SL 0.3 mg SL PRN chest pain 
6. Lorazepam 1 mg PO QID:PRN anxiety 
7. Metoclopramide 5 mg PO QIDACHS 
Take 30 mins prior to meals. 
8. Ezetimibe 10 mg PO DAILY 
9. Rosuvastatin Calcium 40 mg PO DAILY 
10. Sertraline 100 mg PO DAILY 
11. Aspirin 325 mg PO DAILY 
12. Ferrous GLUCONATE 324 mg PO DAILY 
13. HYDROmorphone (Dilaudid) ___ mg PO Q4H 
14. Lanthanum 1000 mg PO TID W/MEALS 
15. Warfarin 2 mg PO DAILY 
16. Nephrocaps 1 CAP PO DAILY 
17. Glargine 6 Units Breakfast
Glargine 25 Units Bedtime
Humalog 3 Units Breakfast
Humalog 3 Units Lunch
Humalog 3 Units Dinner

 
Discharge Medications:
1. Gabapentin 100 mg PO BID 
2. Nitroglycerin SL 0.3 mg SL PRN chest pain 
3. Sertraline 100 mg PO DAILY 
4. Rosuvastatin Calcium 40 mg PO DAILY 
5. Omeprazole 40 mg PO DAILY 
6. Metoclopramide 5 mg PO QIDACHS 
7. Lorazepam 1 mg PO QID:PRN anxiety 
8. Lanthanum 1000 mg PO TID W/MEALS 
9. HYDROmorphone (Dilaudid) ___ mg PO Q4H 
RX *hydromorphone 4 mg ___ tablet(s) by mouth every four hours 
Disp #*100 Tablet Refills:*1
10. Ferrous GLUCONATE 324 mg PO DAILY 
11. Ezetimibe 10 mg PO DAILY 
12. Aspirin 325 mg PO DAILY 
13. Nephrocaps 1 CAP PO DAILY 
14. Nystatin Cream 1 Appl TP BID Fungal infection 
15. Lactulose 30 mL PO TID 
RX *lactulose 10 gram/15 mL 30 ml by mouth three times a day 
Disp #*2 Bottle Refills:*0
16. Collagenase Ointment 1 Appl TP DAILY 
RX *collagenase clostridium hist. [Santyl] 250 unit/gram Apply 
to left foot ulcer once daily Disp #*2 Tube Refills:*0
17. Glargine 5 Units Breakfast
Glargine 15 Units Bedtime
Humalog 3 Units Breakfast
Humalog 3 Units Lunch
Humalog 3 Units Dinner
Insulin SC Sliding Scale using HUM Insulin
18. Bisacodyl 10 mg PO/PR DAILY:PRN constipation 
19. Docusate Sodium 100 mg PO BID:PRN constipation 
20. Senna 1 TAB PO HS 
21. Sodium Thiosulfate 25 g IV Q3WEEKLY 
22. Minocycline 100 mg PO BID 
RX *minocycline 100 mg 1 capsule(s) by mouth two times per day 
Disp #*30 Capsule Refills:*0
23. Outpatient Lab Work
Lupus Anticoagulant

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Gangrene R ___ finger

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to wheelchair.

 
Discharge Instructions:
Please weight yourself every day. If your weight goes up more 
than 3 lbs please contact your doctor.

Please note the following important changes in your home 
medication:

1. Midodrine and Warfarin have been stopped. Your physicians 
___ the need for these medicines during follow-up 
but donot take these unless specifically instructed.

2. Your insulin regimen has been changed. You were previously 
taking Lantus 6units in the morning and 25 units at bedtime 
along with Novolog and sliding scale insulin. This regimen has 
been changed to Lantus 5 units in the morning and 15 units at 
bedtime alongwith 3 units of humalog before each meal. Please 
refer to the chart that is included with your discharge 
paperwork.

3. You are being started on sodium thiosulphate 25g thrice a 
week. This will be administered to you during your dialysis 
sessions. We have already discussed this with Dr. ___ you 
should also contact him in case you have any questions.
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=15521468-DS-21 | hadm_id=20606639

 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Bactrim / Nafcillin / Lisinopril / difficult intubation requires 
LMA
 
Attending: ___.
 
Chief Complaint:
Shortness of breath
 
Major Surgical or Invasive Procedure:
None.
 
History of Present Illness:
___ y/o F with hx of extensive CAD s/p 5 vessel CABG in ___, 
ESRD ___ DMII, and HTN p/w 2 night hx of SOB with episode of 
shoulder blade discomfort. Pt. reports that over the past 2 
nights she has experienced ___ hours long episodes of shortness 
of breath while sleeping in her usual recliner. During the first 
night, the SOB resolved on its own without any associated 
CP/nausea/HA. However, her episode last night was worse than the 
previous and she subsequently developed ___ left scapular pain 
described as crushing pressure, which she reports having been 
similar to her anginal equivalent in the past. She denied any 
chest/arm/jaw pain, nausea, or other discomfort during this 
episode. It resolved in 3 hours and she slept the rest of the 
evening. She checks her weight daily and reports no recent 
weight gain, no medicine non-compliance, no increased salty food 
intake, no fevers, chills, fatigue, cough, nausea, vomiting, 
diarrhea, abdominal pain, weakness, numbness, headache, or 
visual changes.
 
In the morning, her family urged her to see her PCP. Her PCP 
found increased ___ inversions in the lateral leads from her 
baseline and sent her to the ED. Her vitals on arrival were 97.9 
116 94/58 20 96% on 2L NC. EKG showed lateral ___ inversions 
compared to and roughly stable from her baseline. BNP 
significantly elevated from her baseline of 5000s to the 16000s. 
She was admitted to ___ for further evaluation and management. 
During the evening of her admission, she also reported mild 
___ L arm pressure not associated with any other symptoms, 
self-resolved in 30 minutes.
 
Past Medical History:
-CAD s/p CABG ___ (LIMA to LAD, SVG to PDA, OM1, OM2, D1) 
Cath ___ all SVG occluded, stent to Lcx,Om1. Cath ___ ISR, 
brachytherapy. ___ stents to OM1, LCx. ___ OM occluded.
-DMII c/b retinopathy, neuropathy
-HTN
-HL
-dCHF EF 55%
-Chronic renal failure
-Obesity
-charcot ankle on left with osteomyelitis ___
-Intestinal Dieulafoy's (Hemorrhagic) Lesion
 
Social History:
___
Family History:
She reports her mother developed lung cancer, she was a smoker. 
She had a grandmother and an aunt who had breast cancer, 
grandmother was diagnosed with breast cancer in her ___ and her 
aunt was in her ___. There is no other family history of cancer.
 
Physical Exam:
ADMISSION:
98.4 133/82 73 16 98% 2.5L NC
GEN: Well-developed, obese female appearing stated age lying 
comfortably in bed in NAD
NECK: JVD at >14 cm
COR: Normal rate, regular rhythm. Accentuated P2. II-III/VI 
systolic murmur at R ___ intercostal space.
PULM: Lungs with faint bibasilar crackles, no rhonchi or 
wheezes.
___: + NABS in 4Q. Soft, NTND.
EXT: trace ___ edema, reportedly at baseline. warm, 
well-perfused. 2+ ___ pulses. No clubbing or cyanosis. L 
Charcot foot deformity with large surgical scar.
NEURO: MAEE. CN II-XII intact.

DISCHARGE:
VITAL SIGNS: 98.3 155/89 (133-187/80-88) 70 (70-76) 99% on 3L 
___ 3L NC) 111.6kg from ___ yesterday (just received PD 
fluids in)
GEN: Well-developed, obese female appearing stated age lying 
comfortably in bed in NAD
NECK: JVD at 12 cm
COR: Normal rate, regular rhythm. Accentuated P2. II-III/VI 
systolic murmur at R ___ intercostal space.
PULM: CTAB, no crackles, rhonchi, or wheezes.
___: + NABS in 4Q. Soft, NTND.
EXT: trace stable ___ edema, reportedly at baseline. warm, 
well-perfused. L Charcot foot deformity with large surgical 
scar.
NEURO: MAEE.
 
Pertinent Results:
ADMISSION:

___ 01:45PM BLOOD Glucose-261* UreaN-48* Creat-3.8* Na-141 
K-4.1 Cl-103 HCO3-26 AnGap-16
___ 01:45PM BLOOD ___ PTT-30.1 ___
___ 01:45PM BLOOD WBC-8.4 RBC-3.43* Hgb-9.9* Hct-31.4* 
MCV-92 MCH-28.9 MCHC-31.5 RDW-17.8* Plt ___
___ 01:45PM BLOOD CK-MB-3 cTropnT-0.33* ___
___ 01:45PM BLOOD CK(CPK)-41
___ 01:45PM BLOOD Calcium-9.3 Phos-3.8# Mg-1.8

OTHER RELEVANT:

___ 09:35PM BLOOD CK-MB-2 cTropnT-0.31*
___ 07:51AM BLOOD CK-MB-2 cTropnT-0.39*
___ 09:35PM BLOOD CK(CPK)-36
___ 07:51AM BLOOD CK(CPK)-32

DISCHARGE:

___ 07:50AM BLOOD Glucose-257* UreaN-49* Creat-4.3* Na-142 
K-4.3 Cl-102 HCO3-31 AnGap-13
___ 07:50AM BLOOD Calcium-9.5 Phos-5.3* Mg-1.9

___ STRESS TEST:
___ year old woman with history of old MI, CABG ___,
insulin-dependent diabetes, chronic kidney disease, 
hypertension,
presenting with shortness of breath and left shoulder 
pain/anginal
equivalent following negative serial enzymes and EKGs for 
pharmacologic
stress test with nuclear imaging. She completed 4 minutes of
dipyridamole infusion at 0.142 mg/kg/min. She had no chest, 
back, arm,
shoulder, neck, or jaw discomfort. Her baseline EKG had TWI in I 
and
aVL with diffuse TW flattening which did not change throughout 
the
study. Her rhythm was sinus with one ventricular couplet on rest 
EKG
without ectopy during study. She had an appropriate hemodynamic
response to dipyridamole infusion. At conclusion of the study,
dipyridamole was reversed with amniophylline 125 mg IV.
IMPRESSION: No anginal symptoms or ST segment changes with 
pharmacologic
stress testing. Nuclear reported separately.

___ ECHO:
The left atrium is mildly dilated. There is mild symmetric left 
ventricular hypertrophy. The left ventricular cavity is 
moderately dilated. There is mild regional left ventricular 
systolic dysfunction with inferior and inferolateral 
hypokinesis. The remaining segments contract normally (LVEF = 
40-45%). Right ventricular chamber size and free wall motion are 
normal. The aortic valve leaflets (3) are mildly thickened but 
aortic stenosis is not present. No aortic regurgitation is seen. 
The mitral valve leaflets are mildly thickened. There is no 
mitral valve prolapse. Moderate to severe (3+) mitral 
regurgitation is seen. There is mild pulmonary artery systolic 
hypertension. There is no pericardial effusion.

IMPRESSION: Mild regional left ventricular systolic function. 
Moderate to severe mitral regurgitation. Mild pulmonary 
hypertension.

Compared with the prior study (images reviewed) of ___, 
regional LV systolic dysfunction is now more apparent.  

___ CARDIAC PERFUSION:
SUMMARY FROM THE EXERCISE LAB:
Dipyridamole was infused intravenously for 4 minutes at a dose 
of 0.142
milligram/kilogram/min. 
 
IMAGING METHOD:
Stress images were obtained with Tc-99m sestamibi. Tracer was 
administered
intravenously two minutes after the cessation of infusion of 
dipyridamole.
Stress images were obtained approximately 45 minutes following 
tracer
injection.
Resting perfusion images were obtained with Tc-99m sestamibi the 
day following
pharmacologic stress. Tracer was injected 45 minutes prior to 
obtaining the
resting images.
Image Protocol: Gated SPECT
This study was interpreted using the 17-segment myocardial 
perfusion model.
 
INTERPRETATION:
There is considerable attenuation by overlying soft tissue.
Left ventricular cavity size is moderately enlarged.
Resting and stress perfusion images reveal a moderate defect in 
the
inferolateral wall with only a small amount of reversibility.
 
Gated images reveal septal wall motion compatible with prior 
cardiac surgery.
The calculated left ventricular ejection fraction is 33%.
 
Compared with the prior exercise stress study of ___, 
there is somewhat
less reversibility in the inferolateral wall.
 
IMPRESSION:  Moderate defect in the inferolateral wall with a 
small amount of
reversibility.  Decrease ventricular function with a moderately 
enlarged
ventricle and a LVEF of 33%.  There has been little change since 
the study of
___.
 
Brief Hospital Course:
___ y/o F with extensive CAD history s/p 5 vessel CABG, ESRD on 
PD ___ DMII and HTN p/w 2 night history of SOB associated with 
back/scapular discomfort.

ACTIVE DIAGNOSES:

# Acute on Chronic Diastolic Heart Failure Dysfunction with 
Shortness of breath: Given her dependence on peritoneal 
dialysis, her history of diastolic heart failure, her shortness 
of breath when slightly more recumbent at night, significantly 
elevated JVP at >14cm on admission, significantly elevated BNP > 
16000 and above baseline, the etiology of her shortness of 
breath is most likely due to fluid and pressure overload. She 
was diuresed with IV Lasix during her hospital course and 
experienced significant improvement in her shortness of breath. 
Her weight remained relatively stable with clear lungs and lack 
of significant increase in ___ edema on presentation, however 
even a small amount of fluid overload in a patient with ESRD and 
diastolic dysfunction may result in shortness of breath, and her 
JVD suggests continued fluid or pressure overload. She was 
continued on her home diuretics metolazone and torsemide, and 
renal was consulted for increasing the volume of fluid removed 
during her PD. By the time of discharge, she had returned to her 
baseline and had no further complaints. She will follow-up with 
nephrology for further management.

# Scapular/Arm pain:
Given her extensive CAD history, report of scapular discomfort 
being her anginal equivalent, and initial troponin of 0.33, 
there was initially concern for NSTEMI/ACS. Her EKG changes were 
quite subtle and non-specific, however, with relatively stable 
___ inversions and minimal ST depression stable compared to 
baseline. Additionally, her troponins run in the 0.2s to 0.3s 
from her chronic renal insufficiency. Due to the lack of 
ischemic EKG changes, lack of significant bump of her troponins, 
as well as negative CK-MB, the etiology of both her enzymes and 
physical discomfort are likely the result of fluid overload and 
subsequent demand ischemia rather than an acute thrombotic 
event. She had been started on a heparin gtt, given aspirin, 
beta-blocker, and her other home meds, however the heparin gtt 
was stopped after further assessment and discussion with the 
cardiology team. She is currently not having any discomfort. 
Still, to rule out the possibility of CAD contributing to her 
pain, she underwent a pharmacological stress test, which showed 
stable defect in the inferolateral wall. No further 
interventions were performed. She will follow-up with her PCP as 
needed.
 
CHRONIC DIAGNOSES:

# CRI:
On nightly peritoneal dialysis. She will undergo PD tonight in 
the hospital in order to take off as much fluid as possible and 
relieve her fluid overload. She will follow-up with nephrology 
and continue her home regimen of medications for now.
 
# HTN:
Moderately hypertensive since admission. Will add 10mg 
amlodipine daily. Will continue on her other home medications.
 
# DMII:
Reported recent A1c of 6.8. Will maintain on fixed Lantus and 
SSI Humalog while in hospital.
 
 
Medications on Admission:
Preadmission medications listed are correct and complete.  
Information was obtained from PatientwebOMR.
1. Nephrocaps 1 CAP PO DAILY 
2. Ezetimibe 10 mg PO DAILY 
3. Gabapentin 300 mg PO DAILY 
4. Gentamicin 0.1% Cream 1 Appl TP DAILY 
to PD catheter site 
5. Glargine 30 Units Bedtime
Insulin SC Sliding Scale using HUM Insulin
6. Lorazepam 1 mg PO Q8H:PRN anxiety 
7. Metoclopramide 5 mg PO QIDACHS 
8. Metolazone 5 mg PO QMOWEFR 
9. Metoprolol Succinate XL 50 mg PO DAILY 
10. Ranitidine 150 mg PO DAILY 
11. Rosuvastatin Calcium 40 mg PO DAILY 
12. Sertraline 100 mg PO DAILY 
13. sevelamer CARBONATE 800 mg PO TID W/MEALS 
14. Torsemide 100 mg PO DAILY 
15. Aspirin 325 mg PO DAILY 
16. Docusate Sodium 100 mg PO BID:PRN constipation 
17. Ferrous Gluconate 325 mg PO DAILY 

 
Discharge Medications:
1. Aspirin 325 mg PO DAILY 
2. Docusate Sodium 100 mg PO BID:PRN constipation 
3. Ezetimibe 10 mg PO DAILY 
4. Ferrous Gluconate 325 mg PO DAILY 
5. Gabapentin 300 mg PO DAILY 
6. Gentamicin 0.1% Cream 1 Appl TP DAILY 
to PD catheter site 
7. Glargine 30 Units Bedtime
Insulin SC Sliding Scale using HUM Insulin
8. Lorazepam 1 mg PO Q8H:PRN anxiety 
9. Metoclopramide 5 mg PO QIDACHS 
10. Metolazone 5 mg PO QMOWEFR 
11. Metoprolol Succinate XL 50 mg PO DAILY 
12. Nephrocaps 1 CAP PO DAILY 
13. Ranitidine 150 mg PO DAILY 
14. Rosuvastatin Calcium 40 mg PO DAILY 
15. Sertraline 100 mg PO DAILY 
16. sevelamer CARBONATE 800 mg PO TID W/MEALS 
17. Torsemide 100 mg PO DAILY 
18. Amlodipine 10 mg PO DAILY 
RX *amlodipine 10 mg 1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*1

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Acute on Chronic Diastolic Heart Failure
Hypertension
Chronic renal insufficiency
Diabetes Mellitus, type II
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.
 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure to take care of you during your 
hospitalization. You were admitted for shortness of breath and 
back/shoulder pain. During your stay, you were found to have 
retained too much fluid in your body and your blood pressure was 
elevated. Through medications and dialysis, we removed much of 
this excess fluid and we also controlled your blood pressure 
with new medications.

You underwent a stress test which showed a small area of 
reversible ischemia. As we discussed, the risks of giving you 
contrast for a cardiac catheterization are likely much greater 
than the potential benefits. If you have more symptoms you 
should call your cardiologist.

The nephrologists recommended changes to your peritoneal 
dialysis. One of your dwells was increased to 4.25%. The rest 
are unchanged from before. You should call your nephrologist 
first thing on ___ morning to discuss follow-up and any 
further changes. 

Please continue to weigh yourself every morning, and call your 
doctor if weight goes up more than 3 lbs. Please also continue 
to take all of your medications as prescribed.
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=15521468-DS-17 | hadm_id=20719497

 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Bactrim / Nafcillin / Lisinopril
 
Attending: ___
 
Chief Complaint:
Shortness of breath and weight gain
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
Ms. ___ is a ___ y/o female with a history of poorly 
controlled DM2, CAD s/p 5 vessel CABG, who presents with 3 weeks 
of gradually worsening SOB, intermittent back pain/CP at night, 
oxygen desaturation to 78% on RA up to 91% on 4 L/min NC. She 
states that she was doing well with her physical therapy when 
she noticed that she was gaining weight and not able to do as 
much. She noted that she was gaining a lot of fluid and was 
becoming uncomfortable. She went to see her PCP because of this 
and she was noted to be volume overloaded and sent to the 
emergency room.

Of note, she had a prolonged hospital (~1 month ___ in which 
she developed osteomyletis. She also was noted to have an 
exacerbation of her congestive heart failure. She received 80 mg 
IV Lasix and was discharged on IV Lasix however she presented on 
40 mg of PO Lasix.

In the ED her vitals were T 98.1, BP 187/88, HR 66, O2 sat 78% 
on RA. She was placed on oxygen and sats came up to the mid 90's 
with 4 L/min O2. He was placed on nitroglycerin drip, aspirin 
325mg, Lasix 40 mg IV, Levofloxacin 750 mg IV. She was noted to 
have crackles in the lungs, had 2+ pitting edema, CXR appeared 
fluid overload (?infiltrate, but likely CHF, BNP=20,000).

On review of systems, she denies any prior history of stroke, 
TIA, deep venous thrombosis, pulmonary embolism, bleeding at the 
time of surgery, myalgias, joint pains, cough, hemoptysis, black 
stools or red stools. She denies recent fevers, chills or 
rigors. She denies exertional buttock or calf pain. All of the 
other review of systems were negative.

Cardiac review of systems is notable for absence of chest pain, 
dyspnea on exertion, paroxysmal nocturnal dyspnea, orthopnea, 
ankle edema, palpitations, syncope or presyncope.
 
Past Medical History:
She has had diabetes for a long period of time and her most 
recent hemoglobin A1c level was notably elevated at 14%. She has 
a history of coronary artery disease and had a CABG in ___. She 
has a history of hyperlipidemia and hypertension. With respect 
to her bypass, she has had stents placed as well. Her CABG was 
complicated by a sternal wound infection. Her most recent echo 
was obtained on ___. This revealed ejection fraction of 
greater than or equal to 55% with no evidence of endocarditis.  
She has never had a colonoscopy and she had her last mammogram 
___ years ago. She also has anemia and her most recent 
hematocrit was 30%. She has an elevated platelet level greater 
than 500.
* CAD s/p 5v CABG in ___, with subsequent 4v CABG 6 months 
later
* DM2, diagnosed in ___, complicated by retinopathy and 
neuropathy, poorly controlled
* HTN
* hyperlipidemia
* anemia

PAST SURGICAL HISTORY:  In ___ and ___, she had her coronary
artery bypass.  She has had three C-sections.

OB/GYN HISTORY:  She denies any history of pelvic infections. 
She denies any history of abnormal Pap smears, and her last was
obtained in ___.  She denies any complications of cesarean
section.
 
Social History:
___
Family History:
She reports her mother developed lung cancer, she was a smoker. 
She had a grandmother and an aunt who had breast cancer, 
grandmother was diagnosed with breast cancer in her ___ and her 
aunt was in her ___. There is no other family history of cancer.
 
Physical Exam:
ON ADMISSION:
GENERAL: Overweight middle aged Caucasian woman, comfortable in 
NAD, she was awake alert and oriented x3, mood, affect 
appropriate.
VS: T 97.9 BP 161/82 HR 63 O2 sat 91% on 4 L/min
ADMISSION WEIGHT: 137.3 Kg
HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were 
pink, no pallor or cyanosis of the oral mucosa. No xanthalesma.
NECK: Supple with JVP of 10 cm.
CARDIAC: RRR, normal S1, S2. No murmurs, rubs or gallops. No 
thrills, lifts.
LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp 
were unlabored, no accessory muscle use. crackles noted at the 
bases bilaterally, no wheezes or rhonchi.
ABDOMEN: Soft, NTND. No HSM or tenderness.
EXTREMITIES: No clubbing, cyanosis or edema.
SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.
PULSES:
Right: DP 1+
Left:  DP 1+

ON DISCHARGE:
O: VS: T 98.2, BP 116/48 (110s-140s/40s-60s) HR (50s-60s), RR 
20, O2 sat 92% on 2 L/min
I/O: yesterday 104___ (-1300)
Discharge Weight: 105.6
GENERAL: Comfortable in NAD, she was awake alert and oriented 
x3, mood, affect appropriate.
HEENT: NCAT. Sclera anicteric. Conjunctiva pink, no pallor or 
cyanosis of the oral mucosa. No xanthalesma.
NECK: Supple, JVP 8 cm.
CARDIAC: RRR, normal S1, S2. No murmurs, rubs or gallops. No 
thrills, lifts.
LUNGS: Resp unlabored, no accessory muscle use. mild crackles at 
the bases bilaterally, no wheezes or rhonchi.
ABDOMEN: Soft, non-tender, non-distended
EXTREMITIES: 2+ edema noted bilaterally up to the knee
Left ___: dressing clean/dry/intact, 1+ ___ pitting edema
SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.
PULSES:
Right: DP 1+
Left:  DP 1+
 
Pertinent Results:
ADMISSION LABS:
___ 02:23PM BLOOD WBC-6.2 RBC-5.81*# Hgb-15.3# Hct-49.0*# 
MCV-84 MCH-26.4* MCHC-31.3 RDW-19.0* Plt ___
___ 02:23PM BLOOD ___ PTT-22.9 ___
___ 02:23PM BLOOD Glucose-233* UreaN-34* Creat-1.9* Na-141 
K-4.3 Cl-99 HCO3-33* AnGap-13
___ 02:23PM BLOOD cTropnT-0.11*
___ 02:23PM BLOOD ___
___ 05:50AM BLOOD Calcium-8.6 Phos-4.5 Mg-2.0
___ 02:42PM BLOOD Lactate-1.0

DISCHARGE LABS:
___ 06:10AM BLOOD WBC-5.7 RBC-4.01* Hgb-10.9* Hct-33.2* 
MCV-83 MCH-27.1 MCHC-32.8 RDW-17.1* Plt ___
___ 07:10AM BLOOD ___ PTT-26.6 ___
___ 06:10AM BLOOD Glucose-132* UreaN-99* Creat-2.0* Na-138 
K-5.1 Cl-88* HCO3-45* AnGap-10
___ 06:10AM BLOOD Calcium-9.5 Phos-5.3* Mg-2.1

OTHER PERTINENT RESULTS:
PTH-92*
VENOUS Blood Gas: pO2-42* pCO2-68* pH-7.45 calTCO2-49* Base 
XS-18
Vitamin D Level - PENDING AT DISCHARGE

___ ECG:
Sinus rhythm. Baseline artifact. Poor R wave progression. 
Non-specific 
inferolateral T wave flattening. Compared to the previous 
tracing of ___ artifact is more pronounced in the limb leads. 
QRS changes in leads V3-V4 could be due to lead placement. 

___ CXR:
Patient is status post median sternotomy and CABG. There are low 
inspiratory lung volumes. The heart size is moderately enlarged. 
Patchy airspace opacities are seen within the left lung base as 
well as within the right lung base medially. Findings are 
nonspecific and may represent areas of infection or atelectasis. 
A small left pleural effusion is noted. Pulmonary vascularity is 
not engorged, but the vascularity is crowded together due to low 
inspiratory lung volumes. No pneumothorax is visualized.
IMPRESSION: Patchy bibasilar airspace opacities, worse on the 
left, which
could represent atelectasis or infection. Small left effusion.

___ ECHO:
The left atrium is mildly dilated. There is mild symmetric left 
ventricular hypertrophy with normal cavity size and 
regional/global systolic function (LVEF>55%). The right 
ventricular cavity is mildly dilated with mild global free wall 
hypokinesis. The aortic valve leaflets (3) appear structurally 
normal with good leaflet excursion and no aortic regurgitation. 
The mitral valve leaflets are mildly thickened. There is no 
mitral valve prolapse. Moderate (2+) mitral regurgitation is 
seen. The tricuspid valve leaflets are mildly thickened. 
Moderate [2+] tricuspid regurgitation is seen. There is moderate 
pulmonary artery systolic hypertension. There is no pericardial 
effusion.
IMPRESSION: Mild symmetric left ventricular hypertrophy with 
preserved global and regional systolic function. Mild global 
right ventricular systolic dysfunction. Moderate mitral and 
tricuspid regurgitation. Moderate pulmonary hypertension.
  Compared with the report of the prior study (images 
unavailable for review) of ___, right ventricle now appears 
mildly hypokinetic and pulmonary pressures are higher. There may 
be more mitral and tricuspid regurgitation.  

___ ECHO WITH BUBBLES:
The left atrium is normal in size. No atrial septal defect or 
patent foramen ovale is seen by 2D, color Doppler or saline 
contrast with maneuvers. The right atrial pressure is 
indeterminate. There is mild symmetric left ventricular 
hypertrophy with normal cavity size and regional/global systolic 
function (LVEF>55%). Tissue Doppler imaging suggests an 
increased left ventricular filling pressure (PCWP>18mmHg). The 
right ventricular cavity is moderately dilated with mild global 
free wall hypokinesis. There is abnormal septal motion/position 
consistent with right ventricular pressure/volume overload. The 
aortic valve leaflets (3) are mildly thickened but aortic 
stenosis is not present. No aortic regurgitation is seen. The 
mitral valve leaflets are mildly thickened. There is no mitral 
valve prolapse. Moderate (2+) mitral regurgitation is seen. The 
tricuspid valve leaflets are mildly thickened. Moderate to 
severe [3+] tricuspid regurgitation is seen. There is moderate 
pulmonary artery systolic hypertension. There is no pericardial 
effusion.
 Compared with the prior study (images reviewed) of ___, 
the severity of tricuspid regurgitation has increased.  

___ CXR:
PA and lateral chest compared to ___ and ___. 
Moderate cardiomegaly and pulmonary vascular congestion are 
longstanding. Aeration in the left lower lobe has improved since 
___. Whether this is decreased edema or atelectasis is 
radiographically indeterminate, but edema if any is minimal 
currently. Small bilateral pleural effusion, unchanged. No 
pneumothorax.
 
Brief Hospital Course:
Ms. ___ is a ___ y/o female with a history of poorly 
controlled DM2, CAD s/p 5 vessel CABG, who presents with 3 weeks 
of gradually worsening SOB, intermittent back pain/CP at night, 
and desaturation consistent with diastolic congestive heart 
failure exacerbation.

1. Acute on Chronic Diastolic Congestive Heart Failure: Ms. 
___ presented with shortness of breath and weight gain. Her 
previous echo in ___ and her echo during this admission 
showed a preserved EF of 55%. She was on 40 mg of Lasix twice a 
day which was not adequate. She denied any recent chest pain, 
fevers, chills, or large salt intake. She was treated with a 
Lasix drip throughout the admission with a goal of ___ liters 
negative per day. Metolazone 10 mg twice a day was added to her 
regimen. During the hospitalization, Ms. ___ weight 
decreased by more than 30 kg. Her shortness of breath improved.

2. Coronary Artery Disease: Ms. ___ has a significant 
history of CAD and has had multiple interventions in the past. 
She was chest pain free throughout her admission. We continued 
aspirin 81 mg daily, atorvastatin 80 mg daily, isosorbide 
mononitrate 60 mg daily, and metoprolol 100 mg daily.

3. Oxygen Requirement: On admission, Ms ___ had a new oxygen 
requirement. On arrival, her O2 sat was 78% on RA, which 
improved to 91% on 4 L/min. As she was diuresed, her oxygen 
requirement decreased and on discharge, O2 sat was 92% on 2 
L/min. At discharge, a chest x-ray was repeated, which did not 
show pneumonia to explain the oxygen requirement. The patient 
had an echo with bubbles to evaluate for shunting, which did not 
reveal a right-to-left shunt. Ms. ___ will have home oxygen. 
She has follow-up in pulmonary clinic.

4. Chronic kidney disease: Ms. ___ creatinine was slightly 
increased above baseline, which is likely multifactorial, 
secondary to both poor forward flow and diabetic nephropathy. 
Her ___ was held during her hospitalization and re-started prior 
to discharge. She also had elevated phosphorus, but a calcium 
phosphorus product less than 50. She has an elevated PTH. This 
abnormality may be consistent with secondary hyperparathyroidism 
due to renal failure. The patient has follow-up with renal as an 
outpatient.

5. Hypertension: She was noted to be very hypertensive when she 
arrived on the floor. She denied having any headaches or changes 
in her vision. She was initially treated with hydralazine 25 mg 
PO q6, metoprolol and amlodipine. Her blood pressure was better 
controlled. At discharge, the hydralazine was stopped and ___ 
restarted.

6. Type 2 Diabetes: She has poorly controlled diabetes with an 
A1c of 10.9 in ___. She is on insulin at home and was continued 
on  her home regimen.

7. Hyperlipidemia: Continued home regime of atorvastatin 80 mg 
daily.
 
Medications on Admission:
Amlodipine 10 mg PO/NG DAILY
Aspirin 81 mg PO/NG DAILY
Atorvastatin 80 mg PO/NG DAILY
Gabapentin 300 mg PO/NG TID
HYDROmorphone (Dilaudid) 2 mg PO/NG Q12H:PRN Pain
Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY
Metoprolol Succinate XL 100 mg PO DAILY
Omeprazole 20 mg PO BID
Sertraline 100 mg PO/NG DAILY
Lasix 40 mg BID
 
Discharge Medications:
1. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable 
PO DAILY (Daily).
2. atorvastatin 80 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).
3. amlodipine 5 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).
4. gabapentin 300 mg Capsule Sig: One (1) Capsule PO TID (3 
times a day).
5. isosorbide mononitrate 60 mg Tablet Sustained Release 24 hr 
Sig: Two (2) Tablet Sustained Release 24 hr PO DAILY (Daily). 
Disp:*60 Tablet Sustained Release 24 hr(s)* Refills:*0*
6. metoprolol succinate 100 mg Tablet Sustained Release 24 hr 
Sig: 1.5 Tablet Sustained Release 24 hrs PO DAILY (Daily). 
Disp:*45 Tablet Sustained Release 24 hr(s)* Refills:*0*
7. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) 
Capsule, Delayed Release(E.C.) PO BID (2 times a day).
8. sertraline 50 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).
9. hydromorphone 4 mg Tablet Sig: 0.5 Tablet PO Q 12H (Every 12 
Hours) as needed for Pain.
10. metolazone 10 mg Tablet Sig: One (1) Tablet PO once a day: 
Please take prior to torsemide. Disp:*30 Tablet(s)* Refills:*0*
11. torsemide 100 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily). Disp:*30 Tablet(s)* Refills:*1*
12. insulin glargine 100 unit/mL Cartridge Sig: ___ (22) 
Units Subcutaneous once a day.
13. insulin lispro 100 unit/mL Cartridge Sig: AS DIRECTED  
Subcutaneous QACHS: Please take insulin as per sliding scale.
14. metoclopramide 10 mg Tablet Sig: 0.5 Tablet PO QIDACHS (4 
times a day (before meals and at bedtime)): Please take 30 
minutes prior to meals. Disp:*60 Tablet(s)* Refills:*0*
15. Cozaar 50 mg Tablet Sig: One (1) Tablet PO once a day.
16. Ativan 1 mg Tablet Sig: As previously directed prior to 
admission Tablet PO once a day.
17. ferrous gluconate 324 mg (38 mg Iron) Tablet Sig: One (1) 
Tablet PO once a day.
18. Outpatient Lab Work
Chemistry - Na, K, Cl, HCO3, BUN, Cr
___
Please fax results to PCP ___ at ___
 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Primary:
Acute on Chronic Diastolic Congestive Heart Failure

Secondary:
Coronary Artery Disease
Hypertension
Diabetes Mellitus
Chronic renal insufficiency
Hypoxemia
Hyperlipidemia
Anemia
Hyperphosphatemia
Secondary hyperparathyroidism
 
Discharge Condition:
Oxygen requirement of 3 L/min (sat 92% on 3L)

Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).
 
Discharge Instructions:
Dear Ms. ___,

You were admitted to the hospital with a congestive heart 
failure exacerbation.   You were given medication to remove 
fluid from your body and your symptoms improved.  Since you were 
admitted, you have required oxygen to maintain adequate oxygen 
in your blood.  We are sending you home with oxygen.  You will 
also have follow-up with the pulmonary doctors.  

You need to have your labs checked on ___.  Please have these 
checked and sent to your primary care doctor to have your 
electrolytes evaluated. We also found that you have some injury 
to your kidneys.  This is likely causing your phosphorus to be 
elevated.  We are going to have you follow-up with the kidney 
doctors as ___ outpatient.  

You were started on a diuretic called torsemide to help keep the 
fluid from reaccumulating.  Torsemide is a stronger diuretic 
than furosemide.  

The following changes were made to your medications:
1. Added torsemide 100 mg PO daily
2. Added Metolazone 10 mg daily (please take this medication 
prior to the torsemide)
3. Stopped Furosemide 40 mg PO BID
4. Increased your dose of Isosorbide Mononitrate to 120 mg daily 
from 60 mg daily
5. Increased your dose of Metoprolol Succinate XL to 150 mg 
daily from 100 mg daily
6. Added Reglan 10 mg prior to meals and bedtime.  Please take 
this medication for gastroparesis.  Take 30 minutes prior to 
discharge. 

Weigh yourself every morning, call MD if weight goes up more 
than 3 lbs.

Please see below for you follow-up appointments. 
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=15521468-DS-18 | hadm_id=20906652

 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Bactrim / Nafcillin / Lisinopril
 
Attending: ___.
 
Chief Complaint:
Weight gain
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
In brief ___ F w hx poorly controlled DM, CAD, CHF w recent 
100lb diuresis, a/f HCT of 28.6 (baseline 33), 14 lb wt gain. 
Patient reports that 2wkw PTA, PCP decreased torsemide from 
100mg to 40mg, after which she started gaining ~2lbs/day. 
Subsequently torsemide increased to 60mg but continued to gain 
wt. In ED vitals signs: Temp 97 58 180/79, RR 24 100%2L 
(baseline). PE w ___.  Guaiac neg.  Labs significant for HCT 
28.8, Cr 2.0 (baseline 1.6), Trop .12, CKMB 4, BNP 4505.  EKG w 
diffuse ST changes.  CXR w bilat small pleural effusions, 
improvement from prior, L-sided atelectasis, no pulm edema.  

Regarding HCT, patient has EGD ___ and colonoscopy ___ both 
negative.  Denied dark stools, bleeding.  
.  
Patient received 80mg IV furosemide in ED w/o bump UOP, received 
200mg IV lasix w good UOP.  
 
Past Medical History:
CARDIAC RISK FACTORS +DM, +HTN +HLD
CARDIAC HISTORY
-CAD s/p 5v CABG in ___, with subsequent 4v CABG 6 months later 
 
-___ EF 50-55%
OTHER MEDICAL HISTORY:
- Charcot ankle on the Left w/ osteo  
- DM c/b retinopathy, neuropathy
- anemia  
 
Social History:
___
Family History:
She reports her mother developed lung cancer, she was a smoker.  

She had a grandmother and an aunt who had breast cancer,  
grandmother was diagnosed with breast cancer in her ___ and her  

aunt was in her ___. There is no other family history of  
cancer. 
 
Physical Exam:
ON ADMISSION
VS: T= 98.6 BP= 170/65 HR= 58 RR= 14 O2 sat= 99% 2L, 91% RA  
GENERAL: NAD. Oriented x3. Mood, affect appropriate, conversant, 
pleasant, well dressed, wearing earings. Able to ___ in 
reverse  
HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were 
pink, no pallor or cyanosis of the oral mucosa. No xanthalesma.  

NECK: Supple with JVP up to mid mandible w/ abd compression  
CARDIAC: RRR, III/VI HSM diffusely across precordium  
LUNGS: Crackles in lower half w/ decreased BS at bases 
bilaterally  
ABDOMEN: Soft, NTND. BS+, obese  
EXTREMITIES: 1+ pittind edema to knee bilaterally w/ well healed 
surgical scar on L lower leg  
SKIN: stasis dermatitis in lower extremities bilaterally L>R  
PULSES:  
Right: Carotid 2+ DP 2+ ___ trace  
Left: Carotid 2+ DP unable to palpate ___ unable to palpate 

ON DISHCARGE
VS: ___, Tm 98.7, Tc 98.7 155/76 65 20 98% 2L
GENERAL: NAD, AOx3, Comfortable
HEENT: PERRL, EOMI, Conjunctiva were pink, no pallor or cyanosis 
of the oral mucosa. 
NECK: Supple w JVP to angle of mandible
CARDIAC: RRR, III/VI HSM diffusely across precordium  
LUNGS: Bibasilar crackles
ABDOMEN: Soft, NT/ND, BS+, obese
EXTREMITIES: 1+ pitting edema to knee bilaterally w/ well healed 
surgical scars, b/l bandages to the knees. 
SKIN: Stasis dermatitis in lower extremities bilaterally L>R
PULSES:  
Right: Carotid 2+ DP 2+ ___ trace  
Left: Carotid 2+ DP unable to palpate ___ unable to palpate 
 
Pertinent Results:
Blood Counts
___ 01:55PM BLOOD WBC-8.5 RBC-3.49* Hgb-9.8* Hct-28.8* 
MCV-82 MCH-28.1 MCHC-34.1 RDW-17.2* Plt ___
___ 07:45AM BLOOD WBC-8.1 RBC-3.58* Hgb-10.0* Hct-29.2* 
MCV-82 MCH-28.0 MCHC-34.3 RDW-16.9* Plt ___

Chemistry
___ 01:55PM BLOOD Glucose-212* UreaN-61* Creat-2.0* Na-142 
K-4.7 Cl-101 HCO3-33* AnGap-13
___ 07:45AM BLOOD Glucose-113* UreaN-69* Creat-2.1* Na-140 
K-4.0 Cl-96 HCO3-36* AnGap-12

Cardiac
___ 01:55PM BLOOD CK-MB-4 proBNP-4505*
___ 01:55PM BLOOD cTropnT-0.12*
___ 07:50AM BLOOD CK-MB-2 cTropnT-0.11*

Iron
___ 07:50AM BLOOD calTIBC-186* ___ Ferritn-384* 
TRF-143*

___
CXR
1. Bilateral small pleural effusions, with interval improvement 
in the left pleural effusion. Mild pulmonary edema. 
2. Interval improvement in the aeration of the left lung base. 
 
Brief Hospital Course:
HOSPITAL COURSE
___ F PMHx poorly controlled DM, CAD, CHF w recent 100lb 
diuresis, a/w 14 lb wt gain in setting of decreased diuresis 
regimen, c/w poor diuresis, no signs of underlying ACS, now 
being diuresed.   
.  
ACTIVE
# dCHF exacerbation: Although the etiology of her chronic dCHF 
remains unknown (its severity far exceeds the extent of her risk 
factors), her acute 14 lb wt gain in the setting of recent 
discontinuation of her metolazone and decreased dosing of her 
torsemide, is believed to be the primary cause of this 
readmission.  Patient was aggressively diuresed, then started on 
a regimen of torsemide, which was uptitrated.  Metolazone was 
not restarted out of concern for overdiuresis in the outpatient 
setting.  At discharge, patient's weight was 91.9. 
.  
# HTN: On admission, patient's HTN was poorly controlled w SBP 
in 140s-150s.  Her metoprolol was changed to carvedilol for 
better afterload control. Carvedilol was then discontinued due 
to hypotension and she was started on metoprolol tartarate and 
will go home on her usual dose of metoprolol.  
.
# Anemia: Patient was admitted w Hct of 28.8, normocytic, with a 
prior colonscopy and EGD both neg, guaiac neg.  It dropped to 23 
and, given her known CAD, she was transfused 1 unit pRBCs.  
Patient remained stable for the remained of this admission.
.
#CKD: Cr elevated to 2.0 (baseline 1.6-1.8), which was thought 
to most likely be ___ to poor forward flow. She will follow up 
this issue with Neprhology as an outpatient next week. 

INACTIVE
# CORONARIES: Patient was continued on home ASA, isosorbide 
mononitrate was uptitrated.  
# DMII: Patient was continued on home glargine 22u QHS and 
sliding scale humalog.  
  
TRANSITIONAL
1. Code status: patient remained full code for the duration of 
this admission
3. Transition of Care: Patient's care was discussed with her 
primary care physician ___.  At discharge patient was 
made follow-up appointments with her PCP, ___ and 
Nephrologist. 
 
Medications on Admission:
1. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable  

PO DAILY (Daily).  
2. atorvastatin 80 mg Tablet Sig: One (1) Tablet PO DAILY  
(Daily).  
3. amlodipine 5 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).  

4. gabapentin 300 mg Capsule Sig: One (1) Capsule PO TID (3  
times a day).  
5. isosorbide mononitrate 60 mg Tablet Sustained Release 24 hr  
Sig: Two (2) Tablet Sustained Release 24 hr PO DAILY (Daily).  
Disp:*60 Tablet Sustained Release 24 hr(s)* Refills:*0*  
6. metoprolol succinate 100 mg Tablet Sustained Release 24 hr  
Sig: 1.5 Tablet Sustained Release 24 hrs PO DAILY (Daily).  
Disp:*45 Tablet Sustained Release 24 hr(s)* Refills:*0*  
7. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1)  

Capsule, Delayed Release(E.C.) PO BID (2 times a day).  
8. sertraline 50 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). 
 
9. hydromorphone 4 mg Tablet Sig: 0.5 Tablet PO Q 8H as needed 
for Pain.  
10. metolazone 10 mg Tablet Sig: One (1) Tablet PO once a day:  
Please take prior to torsemide.  
Disp:*30 Tablet(s)* Refills:*0*  
11. torsemide 60 mg Tablet Sig: One (1) Tablet PO DAILY  
(Daily).  
12. insulin glargine 100 unit/mL Cartridge Sig: ___ (22)  

Units Subcutaneous once a day.  
13. insulin lispro 100 unit/mL Cartridge Sig: AS DIRECTED  
Subcutaneous QACHS: Please take insulin as per sliding scale.  
14. metoclopramide 10 mg Tablet Sig: 0.5 Tablet PO QIDACHS (4  
times a day (before meals and at bedtime)): Please take 30  
minutes prior to meals.  
Disp:*60 Tablet(s)* Refills:*0*  
15. Cozaar 50 mg Tablet Sig: One (1) Tablet PO once a day.  
16. Ativan 1 mg Tablet Sig: As previously directed prior to  
admission Tablet PO once a day.  
 
Discharge Medications:
1. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable 
PO DAILY (Daily).  
2. atorvastatin 80 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
3. gabapentin 300 mg Capsule Sig: One (1) Capsule PO TID (3 
times a day).  
4. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) 
Capsule, Delayed Release(E.C.) PO BID (2 times a day).  
5. hydromorphone 2 mg Tablet Sig: ___ Tablets PO Q8H (every 8 
hours) as needed for pain.  
6. lorazepam 1 mg Tablet Sig: One (1) Tablet PO HS (at bedtime) 
as needed for anxiety.  
7. torsemide 100 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Disp:*30 Tablet(s)* Refills:*2*
8. sertraline 100 mg Tablet Sig: One (1) Tablet PO once a day.  
9. metoprolol succinate 100 mg Tablet Sustained Release 24 hr 
Sig: One (1) Tablet Sustained Release 24 hr PO once a day.  
10. amlodipine 10 mg Tablet Sig: One (1) Tablet PO once a day.
Disp:*30 Tablet(s)* Refills:*2*
11. isosorbide mononitrate 60 mg Tablet Sustained Release 24 hr 
Sig: Two (2) Tablet Sustained Release 24 hr PO DAILY (Daily).
Disp:*60 Tablet Sustained Release 24 hr(s)* Refills:*2*
12. losartan 100 mg Tablet Sig: One (1) Tablet PO once a day.
Disp:*30 Tablet(s)* Refills:*2*

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY
Diastolic Congestive Heart Failure

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Ms. ___,

It was a pleasure taking care of you at ___ 
___.  You were admitted with weight gain. You were 
evaluated and found to have a worsening of your heart failure.  
This was likely due to a recent change in your medications.  You 
were treated with diuresis (removal of fluid) and you are now 
ready for discharge.

It will be important for you to weigh yourself every morning, 
and to call your doctor if your weight increases by more than 3 
lbs in a day.

During this hospitalization the following changes were made to 
your medications:
-continue your home diabetis medications
-STOPPED   metolazone
-INCREASED torsemide to 100 daily
-INCREASED Isosorbide mononitrate to 120 daily
-INCREASED Cozaar to 100 Daily
-Resume taking metoprolol succinate 100mg sustained release 
daily
-INCREASE amlodipine to 10mg daily 
 
Please make sure you go to your follow-up appointments and keep 
a log of your blood pressures and weight. 
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=15521468-DS-14 | hadm_id=22528310

 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: OBSTETRICS/GYNECOLOGY
 
Allergies: 
Bactrim
 
Attending: ___
 
Chief Complaint:
fever
 
Major Surgical or Invasive Procedure:
1. Laparoscopy.
2. Extensive lysis of adhesions.
3. Washings.
4. Bilateral salpingo-oophorectomy.
5. Cystoscopy
6. Colonoscopy
 
History of Present Illness:
___ is a ___ woman with multiple medical problems who 
recently has been discovered to have a sizeable complex adnexal 
mass.  ___ reports essentially a 2-to 3-month history of fever 
of unknown origin, anemia, and elevated platelet count and she 
has been noted also to have an elevated sed rate and C-reactive 
protein.  Because of this, a CT scan was performed at an outside
institution.  A CT performed on ___ revealed a mixed 
solid and cystic right adnexal mass measuring 8.5 cm x 4.5 x 6 
cm.  There is notably stranding in the adjacent fat, 
particularly along the superior aspect of the mass.  The mass 
extends from the adnexal region on the right side to the 
posterior wall of the cecum.  Small mesenteric lymph nodes are 
noted within the adjacent fat and no left-sided adnexal masses 
appreciated.  There is a small amount of free fluid within the 
lower pelvis, but otherwise there are no significant 
abnormalities.  There is no ascites.  There is no evidence of an 
omental cake.  The upper abdomen is normal.  ___ reports that 
tumor markers have been done as well on the outside including a 
CEA level and CA-125  level and evidently these were ? normal.  
She denies any complaints at this time.  She denies fever.  She 
does report right lower quadrant discomfort and having 
experience of blood in her urine, which was associated with the 
urinary tract infection in ___.  Otherwise, she has had no 
symptoms or concerns.
 
Past Medical History:
PAST MEDICAL HISTORY:  ___ has got a number of medical 
problems stemming from hypertension and diabetes.  She has had 
diabetes for a long period of time and her most recent 
hemoglobin A1c level was notably elevated at 14%.  She has a 
history of coronary artery disease and had a CABG in ___.  She 
reportedly has an ejection fraction of 50 to 55%.  She has a 
history of hyperlipidemia and hypertension.  With respect to her 
bypass, she has had stents placed as well.  Her CABG was 
complicated by a sternal wound infection.  Her most recent echo 
was obtained on ___.  This reveals ejection fraction of 
greater than or equal to 55% with no evidence of endocarditis.  
She has never had a colonoscopy and she had her last mammogram 
___ years ago. She also has anemia and her most recent 
hematocrit was 30%.  She has an elevated platelet level greater 
than 500.
.
PAST SURGICAL HISTORY:  In ___ and ___, she had her coronary
artery bypass.  She has had three C-sections.
.
OB/GYN HISTORY:  She denies any history of pelvic infections. 
She denies any history of abnormal Pap smears, and her last was
obtained in ___.  She denies any complications of cesarean
section.
 
Social History:
___
Family History:
She reports her mother developed lung cancer, she was a smoker.  
She had a grandmother and an aunt who had breast cancer, 
grandmother was sick in her ___ and her aunt was in her ___.  
There is no other family history of cancer.
 
Physical Exam:
GENERAL:  She appears her stated age, in no apparent distress.
HEENT:  Normocephalic, atraumatic.  Oral mucosa without evidence 
of thrush or mucosa.  Eyes, sclerae are anicteric.
NECK:  Supple, no masses, no evidence of thyromegaly.
LYMPHATICS:  Lymph node survey, negative cervical, 
supraclavicular, axillary, or inguinal adenopathy.
CHEST:  Lungs clear bilaterally.
HEART:  Regular rate and rhythm.  A systolic murmur is 
appreciated.
ABDOMEN:  Soft, nontender, and nondistended.  There is no hepato 
or splenomegaly.  There is no fluid wave.  There is no palpable 
mass.
EXTREMITIES:  There is no clubbing, cyanosis, or edema.  There 
is no calf tenderness to palpation.
PELVIC:  Normal external genitalia.  Inner labia minora is 
normal.  The urethral meatus is normal.  A speculum was placed.  
The walls of the vagina are smooth.  The cervix is normal.  
There is no cervical motion tenderness.  Bimanual exam reveals 
an anteverted uterus.  There is fullness on the right side.  
There is no nodularity.  There is no mass on the left side. 
RECTAL:  Reveals good sphincter tone without mass or lesion. 
There is no evidence of disease within the rectovaginal septum 
or nodularity.
 
Brief Hospital Course:
Ms. ___ was admitted for perioperative optimization 3 days 
prior to her scheduled laparoscopic bilateral 
salpingo-oopherectomy. The internal medicine service was 
consulted to optimize management of her multiple medical 
problems. She underwent colonoscopy on hospital day 2, which 
showed a 3mm benign-appearing, sessile polyp. She had a 
pre-operative labs, chest x-ray and EKG on hospital day 3; she 
was also seen by anesthesiology. On hospital day 4, she 
underwent laparoscopy, extensive lysis of adhesions, peritoneal 
washings, bilateral salpingo-oophorectomy, and cystoscopy. 
Please see operative note for full details. Her post-operative 
course was characterized by the following:
.
*) fever
She spiked a fever on post-operative day 1. There was no 
leukocytosis and no bandemia. Her EKG showed no changes and CXR 
was clear. In the absence of any other temperature spikes over 
the course of the day, this was thought to be due to a benign 
post-operative fever. She will be discharged home with a 7 day 
course of doxycycline given operative findings suggestive of 
prior PID infection. 
.
*) CAD
She was placed on telemetry and had no events during her 
hospitalization. Her home medications were continued - 
clopidogrel was started on post-operative day 1. Post-op cardiac 
enzymes were checked, found to be negative x2 and EKG showed no 
changes. Electrolytes and CBC were also stable. Ms. ___ was 
without any cardiac complaints for the duration of her hospital 
stay.
.
*) HTN
Home medications were continued. She had no issues during her 
hospitalization.
.
*) insulin-dependent diabetes mettilus
Ms. ___ blood sugars were maintained below 150 during her 
hospital course. She was on her home Lantus and a sliding scale 
insulin.
.
Ms. ___ was eventually discharged on post-operative day 
#2/hospital day #6 in stable condition: afebrile, able to eat 
regular food, under adequate pain control with oral medications, 
and ambulating and urinating without difficulty.
 
Medications on Admission:
AMLODIPINE [NORVASC] - 10 mg Tablet - 1 Tablet(s) by mouth once 
a day
ATORVASTATIN - 80 mg Tablet - 1 Tablet(s) by mouth at bedtime
CLOPIDOGREL [PLAVIX] - 75 mg Tablet - 1 Tablet(s) by mouth once 
a day
ERGOCALCIFEROL (VITAMIN D2) [VITAMIN D] -  (Prescribed by Other 
Provider) - 50,000 unit Capsule - 1 Capsule(s) by mouth Qweek
EZETIMIBE [ZETIA] - 10 mg Tablet - 1 Tablet(s) by mouth once a 
day
FUROSEMIDE [LASIX] - 40 mg Tablet - 1.5 Tablet(s) by mouth once 
a day
GABAPENTIN [NEURONTIN] - 300 mg Capsule - 1 Capsule(s) by mouth 
three times a day
ISOSORBIDE MONONITRATE [IMDUR] - 30 mg Tablet Sustained Release 
24 hr - 1 Tablet(s) by mouth once a day
METOPROLOL TARTRATE [LOPRESSOR] - 100 mg Tablet - 1 Tablet(s) by 
mouth twice a day
NITROGLYCERIN - 0.4 mg Tablet, Sublingual - 1 Tablet(s) 
sublingually as needed
.
Medications - OTC
ASPIRIN - 325 mg Tablet - 1 Tablet(s) by mouth once a day
FERROUS SULFATE -  (Prescribed by Other Provider) - Dosage
uncertain
 
Discharge Medications:
1. Amlodipine 5 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).  

2. Metoprolol Tartrate 50 mg Tablet Sig: Two (2) Tablet PO BID 
(2 times a day).  
3. Furosemide 20 mg Tablet Sig: Three (3) Tablet PO DAILY 
(Daily).  
4. Gabapentin 300 mg Capsule Sig: One (1) Capsule PO Q8H (every 
8 hours).  
5. Nitroglycerin 0.3 mg Tablet, Sublingual Sig: One (1) Tablet, 
Sublingual Sublingual PRN (as needed) as needed for chest pain.  

6. Insulin Glargine  Subcutaneous
7. Vicodin ___ mg Tablet Sig: ___ Tablets PO every ___ hours 
as needed for pain. Disp:*30 Tablet(s)* Refills:*0*
8. Ibuprofen 800 mg Tablet Sig: One (1) Tablet PO every six (6) 
hours as needed for pain. Disp:*30 Tablet(s)* Refills:*0*
9. Colace 100 mg Capsule Sig: One (1) Capsule PO twice a day. 
Disp:*30 Capsule(s)* Refills:*0*

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Right adnexal/pelvic mass
H/o CAD, CABG, DM, high blood pressure

 
Discharge Condition:
Stable

 
Discharge Instructions:
No heavy lifting or vigorous exercise for 6 weeks.  No driving 
while on narcotics.  You may shower, pat your incisions dry.  
Remove the dressings tomorrow evening, the Steri-strips will 
fall off on their own. Call for severe pain not controlled with 
pain medications, fever >101, redness or discharge from your 
incisions, chest pain, shortness of breath, or other concerns. 
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=15521468-DS-27 | hadm_id=22752705

 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
Bactrim / Nafcillin / Lisinopril / difficult intubation requires 
LMA
 
Attending: ___.
 
Chief Complaint:
Leg pain
 
Major Surgical or Invasive Procedure:
___: Left below knee amputation

 
History of Present Illness:
Ms. ___ is a ___ woman with DMII, CAD s/p CABG x4, ESRD on 
daily PD, DMII and history of gangrene of multiple digits of 
both hands with prior amputations of R ___ digits, and 
nonhealing wounds on the left foot. She presents now preop for 
her scheduled below-knee amputation tomorrow. She has been in 
her usual state of health at rehab with no complaints currently, 
other than her foot pain which she states is at baseline for 
her. Of note the patient has a history of difficult intubations.
 
Past Medical History:
- CAD s/p CABG x5 ___ (LIMA-LAD, SVG-PDA, SVG-OM1,
SVG-OM2, SVG-D1, c.b. sternal wound infection. ___:  All
SVGs occluded.  LCX BMS, OM1 BMS. ___: OM PCI/brachy therapy 
for
ISR. ___: DES to OM1 for ISR, DES to LCX for ISR.  Last cath
___: OM filled by collaterals.
- Heart failure with preserved EF: EF 50% (___)  
- DM c/b neuropathy/retinopathy/gastroparesis  HbA1c 6% in 5.13. 
 
- ESRD, peritoneal dialysis.  
- Severe hypotenson: SBPs down to ___, unable to auscultate 
pulse during recent Cardiology apt, started on midodrine in 
___. This was d/c'd during last hospitalization d/t 
gangrene of fingers.  
- Hyperlipidemia  
- Obesity.  
- Depression.  
- Left Charcot foot  
- LLE osteomyelitis ___
- Massive UGI bleed ___, s.p. 12 U PRBC transfusion from 
large gastric ulcer
- LUE DVT involving PICC ___
- MSSA bacteremia ___ 
- Gangrene of multiple digits or Rt hand: s/p Rt ___ finger 
amputation.  
- H/o UGIB  
- H/o LUE DVT 
- Home Oxygen 2L NC  

 
Social History:
___
Family History:
significant for CAD
 
Physical Exam:
On admission:
VS- 98.6  95  120/68  18  100%2L nc
Gen- alert and oriented x3 NAD
CV- RRR
Pulm- easy WOB
Abd- soft, obese, NT ND
Ext- necrotic fingertips L hand, s/p amp R ___ digits with
necrotic ulcers at amputation sites. Multiple dry ulcers over 
the
left foot.
  Fem  Pop  DP  ___
R P    P    D   D
L P    D    D   -

On discharge:
Tm 101 (3PM day prior) Tc 98 HR 87 BP 91/51 RR 14 97% BS 123-167
Gen: NAD
HEENT: MMM
CV: RRR
PULM: CTAB nonlabored breathing
ABD: soft ntnd
Ext: L hand digits ___ necrotic, R hand digits ___ s/p 
amputation, digits ___ with necrotic distal tip, L BKA with 
staples in place healing well in leg immobilizer
Pulse exam
  Fem  Pop  DP  ___
R P    P    D   D
L P    BKA
 
Pertinent Results:
--Hematology--
WBC 14.7, remained elevated, 11.8 on discharge
Hct stable ___ s/p 3U pRBCs
Plts 300s

Cr 5.9-6.7
Trop 0.37-0.43 post-operatively
Phosph ___ stable

EKG ___
Sinus rhythm. Anteroseptal and lateral ST segment changes may be 
due to 
myocardial ischemia. Clinical correlation is suggested. Compared 
to the 
previous tracing of ___ there is no significant interval 
diagnostic changes.  
  Intervals Axes 
Rate PR QRS QT/QTc P QRS T 
94 152 90 ___ 121 
 
CXR ___ Preop
Large region of consolidation in the left lower lobe has been 
present at least to some degree since ___, when chest CT 
showed a large region of atelectasis.  Whether this is 
atelectasis alone or the patient has developed a hypostatic 
pneumonia in the adjacent lung is not determinable from the 
conventional radiographs alone.  The right lung is clear.  The 
heart is top normal size.  Small right pleural effusion is 
present.  There is no pulmonary edema.  A right PIC line ends 
close to the superior cavoatrial junction. 

BKA tissue ___
- Skin, and subcutaneous tissue with ulceration; acute and 
chronic
inflammation and  necrosis.
- Arteries with marked atherosclerosis.
- Bone with changes consistent with chronic osteomyelitis.
 
Brief Hospital Course:
Ms ___ was admitted to the vascular service on ___ 
for pre-op workup prior to an elective left below the knee 
amputation planned for ___.  She had a standard pre-op 
workup done which showed stable ST changes on her EKG and stable 
LLL consolidation on the CKG.  UA was negative.  She was made 
NPO without IVF and started on SQH. She went to the OR on 
___ for a left BKA.  There were no intraoperative 
complications.  She had a slighly elevated troponin 
post-operatively which was 0.37 to 0.43.  She was transfused a 
unit of blood for a drifting hematocrit to 20.8 post-operatively 
on ___.  She was also started on gabapentin.  She underwent 
peritoneal dialysis throughout the admission.  She was restarted 
on her home medications post-operatively including aspirin.  She 
was also started on ceftazipime/cipro/flagyl.  Her knee was 
placed in an immobilizer.  She was made bedrest and on POD1 with 
an order to get out of bed to chair was evaluated by physical 
therapy who recommended that she be sent to rehab after.  She 
was transfused an additional two units of blood on ___.  Her 
diet was advanced to regular on ___ which she tolerated 
well.  She was maintained on CPAP overnight for known OSA.  She 
was transfused again on ___ for a drifting hematocrit. 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 325 mg PO DAILY 
2. Bisacodyl 10 mg PO DAILY:PRN constipation 
3. Collagenase Ointment 1 Appl TP DAILY 
4. Docusate Sodium 100 mg PO BID:PRN constipation 
5. Ezetimibe 10 mg PO DAILY 
6. Ferrous GLUCONATE 324 mg PO DAILY 
7. HYDROmorphone (Dilaudid) 4 mg PO Q4H:PRN pain 
8. Glargine 5 Units Breakfast
Glargine 15 Units Bedtime
Humalog 3 Units Breakfast
Humalog 3 Units Lunch
Humalog 3 Units Dinner
Insulin SC Sliding Scale using HUM Insulin
9. Lactulose 30 mL PO Q8H:PRN constipation 
10. Lorazepam 0.5 mg PO Q6H:PRN anxiety 
11. Lanthanum 1000 mg PO TID W/MEALS 
12. Metoclopramide 5 mg PO TID 
13. Nephrocaps 1 CAP PO DAILY 
14. Nystatin Cream 1 Appl TP BID:PRN fungal infection 
15. Omeprazole 40 mg PO DAILY 
16. Rosuvastatin Calcium 40 mg PO QPM 
17. Senna 1 TAB PO HS 
18. Sertraline 100 mg PO DAILY 
19. Sodium Thiosulfate 25 g IV Q3WEEKLY WITH PD 
20. Acetaminophen 1000 mg PO Q8H:PRN pain 
21. Ondansetron 4 mg IV Q8H:PRN n/v 
22. Epoetin Alfa 30,000 UNIT SC QMOWEFR 
23. Sodium Chloride 0.9%  Flush 10 mL IV PRN line flush 
24. LOPERamide 4 mg PO QID:PRN diarrhea 
25. Mirtazapine 15 mg PO HS 
26. Levothyroxine Sodium 25 mcg PO DAILY 

 
Discharge Medications:
1. Acetaminophen 1000 mg PO Q8H:PRN pain 
2. Aspirin 325 mg PO DAILY 
3. Bisacodyl 10 mg PO DAILY:PRN constipation 
4. Docusate Sodium 100 mg PO BID:PRN constipation 
5. Ezetimibe 10 mg PO DAILY 
6. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN pain 
7. Glargine 5 Units Breakfast
Glargine 15 Units Bedtime
Insulin SC Sliding Scale using HUM Insulin
8. Lactulose 30 mL PO TID 
9. Lorazepam 1 mg PO HS:PRN anxiety 
10. Nephrocaps 1 CAP PO DAILY 
11. Omeprazole 40 mg PO DAILY 
12. Ondansetron 4 mg IV Q8H:PRN n/v 
13. Rosuvastatin Calcium 40 mg PO QPM 
14. Senna 1 TAB PO HS 
15. Sodium Chloride 0.9%  Flush 10 mL IV PRN line flush 
16. Sertraline 100 mg PO DAILY 
17. Lanthanum 1000 mg PO TID W/MEALS 
18. Dextrose 50% 12.5 gm IV PRN hypoglycemia protocol 
19. Gabapentin 300 mg PO BID 
20. Glucagon 1 mg IM Q15MIN:PRN hypoglycemia protocol 
21. Glucose Gel 15 g PO PRN hypoglycemia protocol 
22. Heparin 5000 UNIT SC TID 
23. Heparin Flush (1000 units/mL) 1250 UNIT IV ADD TO EACH PD 
DWELL and PRN, line flush 
24. Metoprolol Tartrate 5 mg IV Q6H:PRN sbp>140  
25. Minocycline 100 mg PO BID 
26. Ferrous GLUCONATE 324 mg PO DAILY 
27. Metoclopramide 5 mg PO TID 
28. Nystatin Cream 1 Appl TP BID:PRN fungal infection 
29. Sodium Thiosulfate 25 g IV Q3WEEKLY WITH PD 
30. LOPERamide 4 mg PO QID:PRN diarrhea 
31. Epoetin Alfa 30,000 UNIT SC QMOWEFR 
32. Collagenase Ointment 1 Appl TP DAILY 
33. Levothyroxine Sodium 25 mcg PO DAILY 
34. Mirtazapine 15 mg PO HS 

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Dry gangrene
Peripheral vascular disease

 
Discharge Condition:
Level of Consciousness: Alert and interactive.
Mental Status: Clear and coherent.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
You were admitted to the hospital for an elective left below the 
knee amputation for chronic ischemic foot pain as well as 
nonhealing leg ulcers from peripheral vascular disease.  You 
were observed after this surgery for a week and you are safe to 
be discharged from the hospital.  Please weigh yourself every 
morning, call MD if weight goes up more than 3 lbs.  Please also 
watch for the danger signs below, and be sure to attend your 
follow up appointment with Dr. ___.
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=15521468-DS-26 | hadm_id=24425177

 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Bactrim / Nafcillin / Lisinopril / difficult intubation requires 
LMA
 
Attending: ___.
 
Chief Complaint:
Fatigue/altered mental status
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
___ year old F with PMH significant for CAD s/p CABG, w/ graft 
stenosis requiring stents x4, DM2, ESRD on peritoneal dialysis, 
Lt Charcot's foot complicated by osteomyelitits, and CHF. She 
was recently hospitalized from ___ on Vascular Surgery 
service for gangrene of Rt ___ finger and discharged on 
minocycline for prophylaxis, for which she was to take for 2 
weeks for treatment of pansensitive pseudomonal foot infection. 
Her warfarin and midodrine were d/c'd during hospitalization. 
Today she presents with 2 days of fatigue.  

In the ED, vitals: T 97.4 89 83/45 18 92% RA. Labs were 
significant for WBC, 24.2 (93.3N,0B, 4.1L0, Cr 7.0, CKMB 18, Tn 
2.23, BNP 37612. EKG showed new ST-depressions in V3-V5. She was 
evaluated by vascular surgery for concern for gangrene and 
osteomyelitis. Exam and pulses felt to be stable from discharge 
on ___: b/l UE fingertip necrosis x 4, finger amp sites x 2, 
and LLE foot wounds. Wo evidence of new purulence or fluctuance. 
They recommended aggressive Abx and no surgical intervention at 
this point. She was given vancomycin/cefepime/metronidazole. 
Patient triggered for hypotension and SPo2 83%. She appeared 
lethargic but still responsive. She was started on central 
levophed and transferred to the MICU for further management. 
Renal dialysis team consulted and she underwent peritoneal 
dialysis in the ED. Vitals prior to transfer afebrile 92 121/60 
15 99%/RA. 

On arrival to the CCU, pt was sleepy, but arousable and 
answering questions appropriately. Pt stated that she was not 
currently in any pain. She endorsed the story noted above, 
stating that she has been feeling more fatigued since she was 
last discharged and then sioce the weekend she has been feeling 
more confused. She specifically denied any CP, palpitations, 
SOB, cough, abdominal pain, N/V/D/C. Her son notes that she has 
been more constipated than usual. He also notes that she has 
been more "out of it" lately. He states that he has been trying 
to limit his mother dilaudid to 4 mg PO QD. Pt also denies any 
foot pain, as she has chronic neuropathy. She states that it 
seems to have been oozing lately, but is not sure how long that 
has been going on. 

 
Past Medical History:
- CAD s/p CABG x5 ___ (LIMA-LAD, SVG-PDA, SVG-OM1,
SVG-OM2, SVG-D1, c.b. sternal wound infection. ___:  All
SVGs occluded.  LCX BMS, OM1 BMS. ___: OM PCI/brachy therapy 
for
ISR. ___: DES to OM1 for ISR, DES to LCX for ISR.  Last cath
___: OM filled by collaterals.
- Heart failure with preserved EF: EF 50% (___)  
- DM c/b neuropathy/retinopathy/gastroparesis  HbA1c 6% in 5.13. 
 
- ESRD, peritoneal dialysis.  
- Severe hypotenson: SBPs down to ___, unable to auscultate 
pulse during recent Cardiology apt, started on midodrine in 
___. This was d/c'd during last hospitalization d/t 
gangrene of fingers.  
- Hyperlipidemia  
- Obesity.  
- Depression.  
- Left Charcot foot  
- LLE osteomyelitis ___
- Massive UGI bleed ___, s.p. 12 U PRBC transfusion from 
large gastric ulcer
- LUE DVT involving PICC ___
- MSSA bacteremia ___ 
- Gangrene of multiple digits or Rt hand: s/p Rt ___ finger 
amputation.  
- H/o UGIB  
- H/o LUE DVT 
- Home Oxygen 2L NC  

 
Social History:
___
Family History:
significant for CAD
 
Physical Exam:
Admission Physical
===================
Vitals  92 121/60 15 99%/RA
General: Laying in bed, sleepy, but arousable, in NAD  
HEENT: PERRL, OP clear, MMM  
Neck: RIJ in place, JVP ~ 9 cm  
CV: RRR, nl S1 and S2, III/VI systolic murmur best heard at the 
___  
Lungs: Clear to auscultation anteriorly, no 
wheezes/rales/ronchi, but limited by pt position  
Abdomen: +BS, soft, distended, NT nontender  
Ext: RLE warm with DP 2+ and 1 cm circular lesion with central 
necrosis at the arch of the foot; LLE warm, erythematous, and 1+ 
edema to sacrum with 2 cm round lesion at the medial malleolus 
without appropriate granulation tissue  
Neuro: A&Ox3, no sensation below knees b/l 

Discharge Physical
===================
VS T 98.9, bp 118/50, p 93, r 18, 98% on 3L
General: Lying in bed. NAD. Skin darkly pigmented. 
HEENT:Right ___ IJ removed yesterday, with bandage, C/D/I
CV: RRR. Holosystolic murmur ___ heard over L & RUSB. Pulses 
felt in all four extremities ___ in LLE, DP and ___ in RLE).
PULM: Lung sounds clear anteriorly
GI: Obese. Soft. Non-tender. 
EXT: Multiple necrotic fingers on R&L. wound vac in place on 
medial LLE adjacent to a necrotic and ulcerated L hallux. Trace 
edema in both calves.
Neuro: A&Ox3
 

 
Pertinent Results:
Admission Labs
=========================
___ 10:30AM BLOOD WBC-24.4*# RBC-3.02* Hgb-8.4* Hct-26.5* 
MCV-88 MCH-27.9 MCHC-31.7 RDW-16.3* Plt ___
___ 06:25AM BLOOD WBC-15.4* RBC-2.60* Hgb-7.0* Hct-23.0* 
MCV-88 MCH-26.8* MCHC-30.4* RDW-16.0* Plt ___
___ 05:15AM BLOOD WBC-12.4* RBC-2.67* Hgb-7.3* Hct-23.6* 
MCV-88 MCH-27.5 MCHC-31.2 RDW-15.8* Plt ___
___ 10:30AM BLOOD Glucose-168* UreaN-32* Creat-7.0* Na-137 
K-3.9 Cl-86* HCO3-21* AnGap-34*
___ 06:25AM BLOOD Glucose-99 UreaN-33* Creat-6.3* Na-137 
K-2.9* Cl-91* HCO3-20* AnGap-29*
___ 02:32AM BLOOD Glucose-93 UreaN-31* Creat-6.0* Na-137 
K-3.2* Cl-91* HCO3-21* AnGap-28*
___ 05:15AM BLOOD Glucose-78 UreaN-33* Creat-6.1* Na-136 
K-3.2* Cl-92* HCO3-20* AnGap-27*
___ 10:30AM BLOOD ___ PTT-30.1 ___
___ 12:09AM BLOOD ___ PTT-43.5* ___
___ 10:30AM BLOOD CK-MB-18* MB Indx-10.9* ___
___ 02:32AM BLOOD CK-MB-10 MB Indx-9.2*
___ 10:42AM BLOOD Lactate-1.7

Inflamatory markers
=====================
___ 06:07AM BLOOD CRP-69.0*
___ 06:25AM BLOOD CRP-187.3*
___ 06:07AM BLOOD ESR-140*
___ 06:25AM BLOOD ESR-140*

Hypercoagulability
====================
___ 14.9* 9.4 - 12.5 sec 
PTT 30.7 25.0 - 36.5 sec 
___ 1.4* 0.9 - 1.1   
INHIBITORS & ANTICOAGULANTS 
Protein C, Functional 99 70 - 170 % 
NOTE NEW ADULT REFERENCE RANGE AS OF ___. 
Protein S, Functional 72 50 - 150 % 
NOTE NEW REFERENCE RANGE AS OF ___ 

Imaging:
===================

FOOT X-RAY ___
IMPRESSION: Overall similar appearance of the foot with 
suspected neuropathic changes and widespread dense arterial 
calcifications.  Overall, there are no radiographic findings 
suggestive of superimposed osteomyelitis, but MR could be 
potentially useful to evaluate further if clinically indicated. 

HAND X-RAY ___
IMPRESSION: Overall similar appearance of the foot with 
suspected neuropathic changes and widespread dense arterial 
calcifications.  Overall, there are no radiographic findings 
suggestive of superimposed osteomyelitis, but MR could be 
potentially useful to evaluate further if clinically indicated. 

CXR___
IMPRESSION: Right internal jugular central venous catheter tip 
terminates within the proximal right atrium.  Persistent mild 
pulmonary edema, small left pleural effusion, and retrocardiac 
opacity, possibly reflecting atelectasis, infection or 
aspiration. 

ECHO ___
There is mild symmetric left ventricular hypertrophy. The left 
ventricular cavity size is normal. Overall left ventricular 
systolic function is low normal (LVEF 50%) secondary to focal 
akinesis/hypokinesis of the posterior wall. Due to the 
technically suboptimal nature of this study, other focal wall 
motion abnormalities cannot be excluded. There are three aortic 
valve leaflets. The aortic valve leaflets are moderately 
thickened. There is a minimally increased gradient consistent 
with minimal aortic valve stenosis. No aortic regurgitation is 
seen. The mitral valve leaflets are moderately thickened. There 
is a probable vegetation (approximately 1 cm) on the anterior 
mitral valve leaflet (atrial side). There is severe mitral 
annular calcification. There is moderate thickening of the 
mitral valve chordae. Moderate (2+) mitral regurgitation is 
seen. Moderate [2+] tricuspid regurgitation is seen. There is 
moderate pulmonary artery systolic hypertension. There is no 
pericardial effusion. 
Compared with the prior study (images reviewed) of ___, a 
probable mitral valve vegetation is now seen.

Microbiology:
 C. difficile DNA amplification assay (Final ___: 
      Negative for toxigenic C. difficile by the Illumigene DNA
      amplification assay. 
           (Reference Range-Negative). 

TISSUE (Final ___: 
      PSEUDOMONAS AERUGINOSA.    RARE GROWTH. 

                              SENSITIVITIES: MIC expressed in 
MCG/ML
                      
_________________________________________________________
                             PSEUDOMONAS AERUGINOSA
                             |   
CEFEPIME--------------     8 S
CEFTAZIDIME-----------     2 S
CIPROFLOXACIN---------   =>4 R
GENTAMICIN------------   <=1 S
MEROPENEM-------------<=0.25 S
PIPERACILLIN/TAZO-----     8 S
TOBRAMYCIN------------   <=1 S

___ 6:07 am BLOOD CULTURE ( MYCO/F LYTIC BOTTLE)
      Source: Line-IJ. 

   BLOOD/FUNGAL CULTURE (Pending): 

   BLOOD/AFB CULTURE (Pending): 

 
Pathology

Bone, left foot (A):

Cartilage and scant bony fragments with reactive changes.

Discharge Labs
=====================
___ 06:18AM BLOOD WBC-13.6* RBC-2.76* Hgb-7.7* Hct-23.9* 
MCV-87 MCH-27.8 MCHC-32.1 RDW-16.2* Plt ___
___ 06:07AM BLOOD Neuts-84.3* Lymphs-10.2* Monos-3.9 
Eos-1.3 Baso-0.2
___ 06:18AM BLOOD Plt ___
___ 06:07AM BLOOD ESR-140*
___ 06:18AM BLOOD Glucose-81 UreaN-35* Creat-6.1* Na-139 
K-4.1 Cl-91* HCO3-21* AnGap-31*
___ 02:32AM BLOOD ALT-54* AST-31 AlkPhos-150* TotBili-0.1
___ 06:18AM BLOOD Calcium-9.1 Phos-5.2* Mg-1.___ with PMH significant for CAD (s/p CABG x5 w/ stent x4), CHF, 
DM2, ESRD requiring peritoneal dialysis, Calciphylaxis, L 
Charcot foot w/ recent osteomyelitis (s/p bone biopsy ___ who 
presented on ___ with 2 days of fatigue and hypotension.

ACTIVE ISSUES

# Hypotension:  

In ED, SBPs were down to ___ and patient met ___ SIRS (tachypnea 
and leukocytosis). In the ED pt was thought to be hypotensive 
___ to septic shock vs cardiogenic shock (troponins elevated, 
discussed further below) and as such she was given 3L fluid and 
started on levophed. Pt was seen by vascular surgery in the ED 
who felt that her gangrenous fingers or her LLE lesion could be 
possible sources of infection, but did not feel that surgery was 
necessary at the time. Pt was started on broad spectrum abx and 
sent to the CCU. 

On arrival to the CCU, it was noted that the pts lactate was not 
elevated and patient was A+Ox3, which indicated adequate 
perfusion. Upon further chart review, it was noted that the 
patient is chronically hypotensive, with SBPs in the 80-90s in 
the afternoon and 70-60s in the AM. She was started on midodrine 
in ___ as she was symptomatic (dizzy, syncope). However, 
this was d/c'd during her last hospitalization d/t gangrene of 
her fingers. Once stable in the CCU, pt was weaned off of 
levophed and pt tolerated with SBPs in 80-90s without any 
pressure support or fluid boluses. She was transfered to the 
medicine.  

On the Medicine floor she was monitored on telemetry. She 
triggered for SBPs in the ___ and received fluid.  Her SBP 
improved to the 120-130s range with fluid and increased PO 
intake.  However her BP would drop to the 70-80s immediately 
after peritoneal dialysis and she required fluid boluses to 
maintain her pressure, and titration of her PD orders by the 
renal service. By discharge her BP had stabilized. Discharge BP 
118/50.   

# LLE Osteomyelitis w/ Leukocytosis: Upon admission, WBC 
elevated to 24.4. Ucx, stool cx, peritoneal cx, bcx, and CXR 
negative for sources of infection. Pt has 2 cm round lesion on 
the LLE that was the likely source. Pt stated that it had been 
oozing more PTA, but not painful, as she has chronic peripheral 
neuropathy. Foot x-ray done in the ED did not show osteo, but 
ESR was 140 and values > 100 indicate possibility of 
osteomyelitis. Podiatry was consulted and bone bx was performed 
to formally determine if pt has osteomyelitis and to tailor abx 
appropriately. She was empirically started on 
vanc/cefepime/flagyl and subsequently switched to vanc/zosyn for 
coverage of MRSA, gram negative, and possible pseudomonal 
infection.  Wound cultures grew psudomonas and serratia.  
Vancomycin and zosyn were continued.  Coverage was planned to be 
narrowed to zosyn alone, but given new mitral valve vegitation, 
it was continued untl ID consult obtained. Pts minocyline was 
stopped. Abx changed to Ceftazidine and Metronidazole to be 
continued for 6 weeks (start date ___ end date ___. 
Podiatry and physical therapy were consulted prior to discharge. 
Left leg cannot bear weight until LLE ulcer has been determined 
healed by outpatient podiatrist. ___ recommended discharge to 
rehabilitation facility for reconditioning.

# NSTEMI: In ED, troponin 2.23, CK-MB 18, and EKG with new 
ST-depressions in lateral leads (notable on EKG from clinic 3 
days prior). It is possible that troponemia was due to ___, 
however patient has chronic troponemia, and her values today are 
5x her normal level and EKG with new changes. Her TIMI score was 
5. Medical management was determined optimal given her extensive 
revascularization history and multiple CABG. On admission pt was 
asymptomatic wo CP, SOB, or nausea/diaphoresis. Pt was continued 
on her home ASA 325 mg, started on heparin gtt, and CE were 
trended. At the time of transfer CE were decreased with troponin 
at 1.95. Heparin gtt was stopped after 24 hours prior to 
transfer to floor, as pt was stable with no new ACS symptoms. 
Normal post NSTEMI beta blocker held due to hypotension. NSTEMI 
considered resolved upon discharge.

# CHF/Mitral valve vegitation: Patient with history of CHF w/ 
preserved EF (HFPEF). Echo in ___ showed EF 50% and 
basal-inferior/infero-lateral hypokinesis. Patient presents 
today with NSTEMI and BNP 37,000 with mild pulmonary edema on 
chest xray. BNP 2 weeks ago 17,000. ECHO was done on ___ and 
revealed left ventricular systolic function atw normal (LVEF 
50%) secondary to focal akinesis/hypokinesis of the posterior 
wall as well as a new mitral valve vegitation. Pt was 
transferred to floor service prior to receipt of these results. 
Dr. ___ primary cardiologist was consulted and 
after reviewing previous echos it could not be definitively 
determined if this vegitation was present previously. It was 
decided that the patient be treated assuming this is a new 
endocarditis lesion. Patient received a TTE which supported 
presensce of vegetation on mitral valve, but patient delined TEE 
which would have provided a clearer view. Antibiotic therapy for 
LLE ulcer will be continued to cover any possible infected 
vegetation though suspicion is very low.
 
# ESRD on peritoneal dialysis: Pt dialyzed in the ED. Renal was 
consulted and recommended renally dosing abx, and gave rec for 
continuing PD, which was followed while pt was in the CCU and 
after transfer to the floor. Home medications were continued, 
including lanthanum, nephrocaps, and bowel regimen with 
lactulose + senna, colace, bisacodyl PRN. Her potassium was low 
___ to cycling of peritoneal dialysis fluid and renal recommend 
removing the potassium restriction on her diet.  If she becomes 
hypokalemic she may need potassium supplementation in her PD 
fluid.  Her lactulose was discontinued secondary to diarrhea.

# Diarrhea: Patient developed diarrhea on medicine floor. C. 
dificile toxin assay from ___ was negative. Diarrhea determined 
to be non-infectious. Reglan reduced to TID and lactulose held. 
On ___ she was started on Loperamide and this was continued as 
needed on discharge for diarrhea.

# Hypercoagulability:  There was concern that an alternative 
explanation for her distal necrosis maybe hypercoagulability 
instead of calciphylaxis.  She has received a thorough workup 
including Lupus ProtCFn ProtSFn ACA IgG ACA IgM, all of which 
were within normal limits.  Note that Lupus Anticoagulant was 
positive when she was on coumadin but negative after 
discontinuation.  In the past she has had normal SPEP and UPEP 
as well.  It may be warranted to pursue further workup of of 
hypercoagulability with Factor V Leiden and a Prothrombin 
Mutation Analysis, but this is of low yield and unlikely to 
explain her clotting.    

CHRONIC ISSUES
# Hyperphosphatemia: ___ ESRD. Pt placed on low phos/K diet and 
lanthanum was continued, as above. Phosphate was 5.0 as of ___.

# Normocytic anemia: Most likely ___ ESRD. Her H/H appeared to 
be[??]at baseline. Pts home ferrous gluconate was continued and 
H/H ranged ___ over the course of her stay. 
Continued iron supplementation is recommended. She received a 
total of 3 units of blood during this hospitalization.

# Calciphylaxis: Patient started on empiric treatment for 
calciphylaxis with IV sodium thiosulphate. Efforts were made to 
get a tissue diagnosis from amputation samples, however the 
slides were not obtainable.  

# HLD: Stable. Home rosuvastatin and ezetimibe continued.

# DM: Stable. Pt continued on outpatient regimen: glargine 5 
units at breakfast and 15 unts at betime. Humalog sliding scale 
(3 units B/L/D).  

# Gasroparesis: Stable. Pt continued on home reglan.  Decreased 
from QID to TID given diarrhea and this can be further titrated 
down while pt has diarrhea, which is thought to be from 
antibiotics.

# Neuropathy: Stable. Per renal recs held gabapentin. 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 325 mg PO DAILY 
2. Bisacodyl 10 mg PO DAILY:PRN constipation 
3. Collagenase Ointment 1 Appl TP DAILY 
4. Docusate Sodium 100 mg PO BID:PRN constipation 
5. Ezetimibe 10 mg PO DAILY 
6. Ferrous GLUCONATE 324 mg PO DAILY 
7. Gabapentin 100 mg PO BID 
8. HYDROmorphone (Dilaudid) 4 mg PO Q4H:PRN pain 
9. Glargine 5 Units Breakfast
Glargine 15 Units Bedtime
Humalog 3 Units Breakfast
Humalog 3 Units Lunch
Humalog 3 Units Dinner
Insulin SC Sliding Scale using HUM Insulin
10. Lactulose 30 mL PO Q8H:PRN constipation 
11. Lanthanum 1000 mg PO TID W/MEALS 
12. Lorazepam 1 mg PO QID:PRN anxiety 
13. Metoclopramide 5 mg PO QIDACHS 
14. Minocycline 100 mg PO Q12H 
15. Nephrocaps 1 CAP PO DAILY 
16. Nitroglycerin SL 0.3 mg SL PRN CP 
17. Nystatin Cream 1 Appl TP BID:PRN fungal infection 
18. Omeprazole 40 mg PO DAILY 
19. Rosuvastatin Calcium 40 mg PO QPM 
20. Senna 1 TAB PO HS 
21. Sertraline 100 mg PO DAILY 
22. Sodium Thiosulfate 25 g IV Q3WEEKLY WITH PD 

 
Discharge Medications:
1. Lift
Patient lift with sling
Diagnosis: Osteomyelitis of left foot and LLE Charcot foot and 
ankle
Reason: difficulty with transfer
2. CefTAZidime 1 g IV Q24H Duration: 42 Days 
start date: ___ 
RX *ceftazidime-dextrose (iso-osm) [Fortaz in dextrose 5 %] 1 
gram/50 mL 1 g Q24h Daily Disp #*42 Unit Refills:*0
3. Aspirin 325 mg PO DAILY 
4. Bisacodyl 10 mg PO DAILY:PRN constipation 
5. Collagenase Ointment 1 Appl TP DAILY 
6. Docusate Sodium 100 mg PO BID:PRN constipation 
7. Ezetimibe 10 mg PO DAILY 
8. Ferrous GLUCONATE 324 mg PO DAILY 
9. HYDROmorphone (Dilaudid) 4 mg PO Q4H:PRN pain 
10. Glargine 5 Units Breakfast
Glargine 15 Units Bedtime
Humalog 3 Units Breakfast
Humalog 3 Units Lunch
Humalog 3 Units Dinner
Insulin SC Sliding Scale using HUM Insulin
11. Lactulose 30 mL PO Q8H:PRN constipation 
12. Lorazepam 0.5 mg PO Q6H:PRN anxiety 
13. Lanthanum 1000 mg PO TID W/MEALS 
14. Metoclopramide 5 mg PO TID 
15. Nephrocaps 1 CAP PO DAILY 
16. Nystatin Cream 1 Appl TP BID:PRN fungal infection 
17. Omeprazole 40 mg PO DAILY 
18. Rosuvastatin Calcium 40 mg PO QPM 
19. Senna 1 TAB PO HS 
20. Sertraline 100 mg PO DAILY 
21. Sodium Thiosulfate 25 g IV Q3WEEKLY WITH PD 
22. Acetaminophen 1000 mg PO Q8H:PRN pain 
23. MetRONIDAZOLE (FLagyl) 500 mg PO Q8H 
24. Ondansetron 4 mg IV Q8H:PRN n/v 
25. Epoetin Alfa 30,000 UNIT SC QMOWEFR Duration: 1 Dose 
26. Sodium Chloride 0.9%  Flush 10 mL IV PRN line flush 
27. LOPERamide 4 mg PO QID:PRN diarrhea 

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Osteomyelitis of left foot
Calciphilaxis
Gangrene of digits
End stage renal disease on peritoneal dialysis
Left charcot foot
Non ST-elevation Myocardial Infarction 
Secondary Diagnoses:  Coronary artery disease, Congestive heart 
failure, Diabetes Type 2, hyperlipidemia, gastroparesis

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Lethargic but arousable.
Activity Status: Bedbound.

 
Discharge Instructions:
Dear ___, 
___  was a pleasure caring for you during your recent admission 
to ___,  You were admitted  for 
fatigue and low blood blood pressure.  You were found to have an 
infection of your left foot that spread to your bone.  We 
treated you with fluids and medications to maintain your blood 
pressure and treated you with antibiotics to control the 
infection.  Your heart was also injured by the low blood 
pressure and we performed tests to look at your heart function.  
While your heart function was unchanged from previous 
hospitalizations there was a concerning lesion found on one of 
your heart valves which could be a sign of an infection.  We 
discussed this infection with our cardiologists and infectious 
disease specialists who agree that you should be treated with 6 
weeks of IV antibiotics. Our vascular surgeons met with you to 
discuss further amputations of your fingers.  You were not 
interested in further amputation at this time, but were 
encouraged to follow up with vascular surgery if the gangrene on 
your fingers spreads or you desire amputation.   You must 
continue to take your IV antibiotics for the next 6 weeks.

THere was also consern that your blood may be more likely to 
clot than normal.  We performed tests to examine this further 
some of the results of these tests are pending.  You should 
follow up with your primary care doctor to obtain the results of 
these tests and determine if further testing is indicated.  
Additionally you should follow up with with all of your doctors 
___ below.

To Do:
1) Do not bear weight on your left leg until a podiatrist says 
that the wound has healed and is ready.
2) Please resume the diet recommended by your endocrinologist 
and primary care doctor. You do not need to continue your low 
phosphate diet.
3) Please follow-up with your outpatient providers. Your 
appointments are listed below.
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=15521468-DS-22 | hadm_id=25303455

 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
Bactrim / Nafcillin / Lisinopril / difficult intubation requires 
LMA
 
Attending: ___.
 
Chief Complaint:
Right hand pain and discoloration
 
Major Surgical or Invasive Procedure:
___: EGD

 
History of Present Illness:
___ w/ h/o CAD s/p CABG x4, multiple cardiac stents, ESRD on PD, 
DM2, and LLE osteo who presents with painful R fingers for past 
week. She noticed "pins and needles" sensation in her right ___ 
digits since last ___. A few days later, she noticed color 
changes to her fingers, up to dark purple hue. She saw her PCP 
today, who referred her to a vascular surgeon, who recommended 
she come to the ED for further evaluation. She has not had any 
other symptoms, denies fevers, chills, nausea, vomiting, chest 
pain, or shortness of breath. Her left had has not had any 
symptoms. She denies specifically a history of atrial 
fibrillation, and she is a non-smoker.
 
Past Medical History:
PMH: CAD s/p CABG and multiple cath/stents, DM2 c/b retinopathy 
and neuropathy, HTN, HL, dCHF, ESRD on PD, obesity, LLE charcot 
ankle c/b osteomyelitis ___ s/p debridement, dieulafoy's lesion 
c/b massive GI bleed

PSH: CABG x5v ___, PD catheter placement 

 
Social History:
___
Family History:
significant for CAD
 
Physical Exam:
Vitals: 98.0, 73, 101/59, 18, 100 3LNC
Gen: NAD, AOx3
CV: RRR, no murmurs
Pulm: CTAB, unlabored
Abd: soft, nontender, nondistended
Ext: WWP lower extremities, minimal edema. faintly palpable
radial pulses in bilateral upper extremity, RUE: ___ digit with
distal ischemia, ___ - ___ digit w/ light purple discoloration 
and slow capillary refill, tender to palpation, dopplerable arch 
signals

 
Pertinent Results:
___ 06:40AM BLOOD WBC-13.2* RBC-2.57* Hgb-8.3* Hct-27.1* 
MCV-106* MCH-32.2* MCHC-30.5* RDW-16.6* Plt ___
___ 06:40AM BLOOD ___ PTT-35.1 ___
___ 06:40AM BLOOD Glucose-144* UreaN-55* Creat-11.1* Na-135 
K-4.0 Cl-89* HCO3-27 AnGap-23*
___ 06:00AM BLOOD ALT-16 AST-15 AlkPhos-95 TotBili-0.3
___ 06:40AM BLOOD Calcium-9.4 Phos-8.6* Mg-2.1
 
Brief Hospital Course:
Patient was admitted to the vascular surgery service on ___ 
with pain and discoloration of her right ___ digit.  A CTA was 
obtained which was significant for:

Patent flow from the aortic arch, right brachiocephalic artery 
to the 
radial and ulnar arteries at the level of the wrist, without 
occlusion or high 
grade stenosis. Multifocal moderate to severe narrowing of the 
distal ulnar 
artery.  Assessment of patency of the arteries distal to the 
wrist within the hand 
is markedly limited due to extensive atherosclerotic 
calcifications and the 
small caliber of these arteries.

Due to concern for arterial embolic disease, she was started on 
a heparin drip.  Because she had a history of GI bleed ___ 
dieulafoy's lesion, a GI consult was obtained to determine risk 
of anticoagulation.  On ___, she was started on coumadin, 5 mg, 
and also received 5 mg on ___. She was started on high dose 
omeprazole, and on ___, GI performed an EGD.  They did not see 
any bleeding or nidus for bleed, however, they were unable to 
perform a full evaluation ___ food in the stomach.  GI 
determined that the area of her previous bleed appeared stable, 
and she would be safe to anticoagulate with a goal INR of 
2.0-3.0 while on omeprazole 40 mg daily.  She was deemed 
appropriate for discharge on ___, and will follow up with Dr. 
___ INR and coumadin dosing.
 
Medications on Admission:
crestor 40', epogen 2000unit/mL, Humalog SSI, Lantus 12u qam 36u 
qpm, renal caps', renvela 800 w/ meals TID, zetia 10', ASA 325', 
ferrous gluconate 324mg', gabapentin 100'', gentamicin topical 
cream to PD site, lorazepam 1' prn, metoclopramide 5'''', 
midodrine 10'', omeprazole 20', sertraline 100'

 
Discharge Medications:
1. Rosuvastatin Calcium 40 mg PO DAILY 
2. Nephrocaps 1 CAP PO DAILY 
3. sevelamer CARBONATE 2400 mg PO TID W/MEALS 
4. Ezetimibe 10 mg PO DAILY 
5. Aspirin 325 mg PO DAILY 
6. Ferrous GLUCONATE 324 mg PO DAILY 
7. Gabapentin 100 mg PO BID 
8. Lorazepam 1 mg PO DAILY:PRN anxiety 
9. Nystatin Cream 1 Appl TP BID 
10. Omeprazole 40 mg PO DAILY 
11. Metoclopramide 5 mg PO QIDACHS 
12. Midodrine 10 mg PO BID 
13. Sertraline 100 mg PO DAILY 
14. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN pain 
RX *hydromorphone [Dilaudid] 2 mg ___ tablet(s) by mouth Q4HRS 
Disp #*80 Tablet Refills:*0
15. Warfarin 2 mg PO DAILY16 
Please start this dose on ___. Follow INR closely while on 
coumadin and adjust dose as needed 
RX *warfarin [Coumadin] 2 mg 1 tablet(s) by mouth Daily Disp 
#*20 Tablet Refills:*0
16. Senna 1 TAB PO BID:PRN constipation 
17. Docusate Sodium 100 mg PO BID 
18. Glargine 12 Units Breakfast
Glargine 36 Units Bedtime
Insulin SC Sliding Scale using HUM Insulin
19. Glucose Gel 15 g PO PRN hypoglycemia protocol 
20. Glucagon 1 mg IM Q15MIN:PRN hypoglycemia protocol 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Right hand ischemia

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
You were admitted to the vascular surgery service with right 
hand pain and color changes in your fingers concerning for 
ischemia.  A CT angiogram showed extensive atherosclerotic 
calcifications in your hand distal to the wrist.  You were 
anticoagulated with a heparin drip, and transitioned to oral 
coumadin (warfarin) to take as an outpatient.  Your INR 
(coumadin level) is now therapeutic, between 2.0-3.0 and you are 
ready to return home.  You will be on coumadin for the next 
three months to treat a likely arterial embolic event.  You 
should follow your INR very closely with your primary doctor, 
and adjust the coumadin dose as needed.  Coumadin puts you at an 
increased risk of bleeding, so please be vigilant in monitoring 
these INR leves as well as any signs/symptoms of bleeding.

Weigh yourself every morning, call MD if weight goes up more 
than 3 lbs.
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=15521468-DS-19 | hadm_id=26686673

 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Bactrim / Nafcillin / Lisinopril
 
Attending: ___.
 
Chief Complaint:
dyspnea
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
___ F with history of CAD s/p CABG and stents, ___ EF 50-55%, 
DMII, HTN, HL, CRI presents with progressive dyspnea. She had 3 
days of SOB and chest pressure. Has noted 3 lb weight gain over 
the last 3 days and increased ___ edema as well. Usually takes 
torsemide 100mg daily, but she increases to 120mg for the last 
___ days because of the weight gain. Oxygen requirement also 
increased from baseline of 2L to 4L. No recent fevers, cough, or 
colds. Denies nausea, vomiting, diarrhea, abdominal pain. Blood 
pressures at home usually 120/70s. Weight on discharge in 
___ was 204 lbs, 3 days ago it was 226.3, today it is 229.2 
lbs. Of note, she recently started erythropoetin injections 
several months ago in treatment of her chronic anemia.

In the ED, initial VS: 98.2 58 197/80 18 100% 4L NC. Patient was 
given lasix 100 mg IV, ASA 325, NTGx1, and nitropaste. Breathing 
improved slightly, and her blood pressure came down to 170s with 
nitro. Vitals on transfer: 98.4 62 187/75 17 99%4l NC

On the floor, patient feels breathing is slightly more improved. 
No current chest pressure pain.

ROS: Denies fever, chills, night sweats, headache, vision 
changes, rhinorrhea, congestion, sore throat, cough, shortness 
of breath, chest pain, abdominal pain, nausea, vomiting, 
diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, 
hematuria.
 
Past Medical History:
-CAD s/p CABG ___ (LIMA to LAD, SVG to PDA, OM1, OM2, D1) 
Cath ___ all SVG occluded, stent to Lcx,Om1. Cath ___ ISR, 
brachytherapy. ___ stents to OM1, LCx. ___ OM occluded.
-DMII c/b retinopathy, neuropathy
-HTN
-HL
-dCHF EF 55%
-Chronic renal failure
-Obesity
-charcot ankle on left with osteomyelitis ___
-Intestinal Dieulafoy's (Hemorrhagic) Lesion
 
Social History:
___
Family History:
She reports her mother developed lung cancer, she was a smoker. 
She had a grandmother and an aunt who had breast cancer, 
grandmother was diagnosed with breast cancer in her ___ and her 
aunt was in her ___. There is no other family history of cancer.
 
Physical Exam:
Admission Exam:
VS: 98.4 168/80 (168-174) 57 18 96RA  Wt105.7kg
GENERAL: NAD, speaking full sentences, AAOx3
HEENT: PERRLA, EOMI, sclerae anicteric, MMM, OP clear.
NECK: Supple, JVP to angle of m
HEART: S1S2, RRR, ___ SEM at apex radiating to the axilla. ___ 
SEM at the LLSB radiating to the sternum.
LUNGS: bibasilar crackles
ABDOMEN: Soft/NT/ND, no masses or HSM, no rebound/guarding.
EXTREMITIES: WWP, 2+ b/l ___ edema, 2+ peripheral pulses. LLE 
scarring from surgical wound.
NEURO: Awake, A&Ox3, CNs II-XII intact, muscle grossly intact

Discharge Exam:
VS:96.9 148/71 70 20 95/2L
WEIGHT: 97.7kg (admit 105.7kg)
GENERAL: well appearing no distress
HEENT: OP clear
NECK: JVP 2 cm shy of mandibular angle
CARDS: RRR, normal S1, ___ SEM at apex radiating to the 
axilla. ___ SEM at the LLSB radiating to the sternum
PULM: faint bibasilar crackles
ABDOMEN: SNT ND +BS no organomegaly
EXT: 1+ pitting edema to ankle.
 
Pertinent Results:
Admission Labs:
___ 03:45PM   PLT COUNT-351
___ 03:45PM   NEUTS-75.7* LYMPHS-16.2* MONOS-4.1 EOS-3.5 
BASOS-0.5
___ 03:45PM   WBC-9.6 RBC-3.41* HGB-10.4* HCT-30.5* MCV-90 
MCH-30.4 MCHC-34.0 RDW-15.4
___ 03:45PM   proBNP-7735*
___ 03:45PM   cTropnT-<0.01
___ 03:45PM   estGFR-Using this
___ 03:45PM   GLUCOSE-161* UREA N-67* CREAT-2.4* SODIUM-143 
POTASSIUM-4.4 CHLORIDE-104 TOTAL CO2-29 ANION GAP-14
___ 11:15PM   CALCIUM-9.1 PHOSPHATE-5.6* MAGNESIUM-2.1
___ 11:15PM   GLUCOSE-164* UREA N-66* CREAT-2.4* 
SODIUM-146* POTASSIUM-4.3 CHLORIDE-107 TOTAL CO2-30 ANION GAP-13

Discharge Labs:
___ 07:55AM BLOOD WBC-6.5 RBC-3.13* Hgb-9.4* Hct-28.5* 
MCV-91 MCH-30.1 MCHC-33.0 RDW-15.1 Plt ___
___ 07:45AM BLOOD Glucose-114* UreaN-71* Creat-3.5* Na-143 
K-4.7 Cl-99 HCO3-39* AnGap-10
___ 07:45AM BLOOD Calcium-9.4 Phos-6.2* Mg-2.3

Notable Labs:
___ 03:45PM BLOOD proBNP-7735*
___ 03:45PM BLOOD cTropnT-<0.01
___ 07:45AM BLOOD CK-MB-3 cTropnT-0.16*
___ 08:30PM BLOOD CK-MB-4 cTropnT-0.16*
___ 07:35AM BLOOD CK-MB-2 cTropnT-0.16*
___ 07:45AM BLOOD CK(CPK)-37
___ 08:30PM BLOOD CK(CPK)-73
___ 07:35AM BLOOD ALT-18 AST-18 LD(LDH)-219 CK(CPK)-58 
AlkPhos-93 TotBili-0.3

Blood Cultures ___ Negative

EKG ___:
Sinus bradycardia. Consider left ventricular hypertrophy, 
although is non-diagnostic. Lateral lead ST-T wave changes with 
borderline prolonged QTc interval may be due to left ventricular 
hypertrophy or possible myocardial ischemia. Clinical 
correlation is suggested. Since the previous tracing of ___ 
there is probably no significant change.

CXR ___:
Patient is status post CABG. Sternotomy sutures are midline and 
intact. Surgical clips noted overlying the left heart border. 
Mediastinal and hilar contours are unremarkable. The left heart 
border is obscured due to a moderate left pleural effusion and 
atelectasis, underlying consolidation not excluded. There is a 
small right pleural effusion. IMPRESSION: Moderate left and 
small right pleural effusion with overlying 
atelectasis;underlying consolidation can not be excluded.

TTE ___:
The left atrium is dilated. There is mild symmetric left 
ventricular hypertrophy with normal cavity size and 
regional/global systolic function (LVEF>55%). Overall left 
ventricular systolic function is normal (LVEF>55%). The right 
ventricular cavity is dilated with depressed free wall 
contractility. The diameters of aorta at the sinus, ascending 
and arch levels are normal. The aortic valve leaflets (3) are 
mildly thickened but aortic stenosis is not present. The mitral 
valve leaflets are moderately thickened. There is a probable 
vegetation on the mitral valve. Moderate (2+) mitral 
regurgitation is seen. [Due to acoustic shadowing, the severity 
of mitral regurgitation may be significantly UNDERestimated.] 
The tricuspid valve leaflets are mildly thickened. Moderate to 
severe [3+] tricuspid regurgitation is seen. There is moderate 
pulmonary artery systolic hypertension. [In the setting of at 
least moderate to severe tricuspid regurgitation, the estimated 
pulmonary artery systolic pressure may be underestimated due to 
a very high right atrial pressure.] There is no pericardial 
effusion. 
IMPRESSION: Mild symmetric left ventricular hypertrophy with 
preserved global left ventricular systolic function. The basal 
inferolateral wall may be mildly hypokinetic. There is a small 
echodensity seen on the posterioro leaflet of the mitral valve 
in the parasternal long axis view. This could be due to artifact 
or to prolapse of part of the leaflet however a vegetation 
cannot be excluded. Moderate mitral regurgitation is seen. The 
RV is not well seen but is probably dilated/depressed with 
moderate to severe tricuspid regurgitation and moderate to 
severe pulmonary artery systolic hypertension. Compared with the 
report of the prior study (images unavailable for review) of 
___, the degree of pulmonary hypertension has increased. 
The echodensity was probably not present on the prior although 
image quality precludes certatinty about this finding.

 
Brief Hospital Course:
Ms. ___ is a ___ diabetic female with severe coronary 
disease, hypertension, hyperlipidemia, diastolic heart failure, 
and previous osteomyelitis of the left ankle who presented in 
acute diastolic heart failure, felt to be triggered possibly by 
starting erythropoetin injections, and who was diuresed to her 
dry weight.

ACTIVE ISSUES:
1. ACUTE ON CHRONIC DIASTOLIC HEART FAILURE:  She noted 
worsening exertional dyspnea with an increased home oxygen 
requirement, lower extremity swelling, and a ___ weight gain 
over the past few months that has been resistant to an increased 
home torsemide dose.  Her BNP was elevated to over 7000 and her 
CXR showed bilateral pleural effusions and edema consistent with 
acute heart failure.  She was diuresed agressively with a 
furosemide gtt and metolazone with good effect.  A repeat 
echocardiogram demonstrated a preserved ejection fraction of 
55%.  Her slowly rising creatinine required intermittent easing 
of her diuretic regimen, though she was eventually returned to 
her dry weight of about 213lb. The precipitant of this 
exacerbation was felt to be secondary to starting erythropoetin 
in the preceding months for her chronic anemia, which is 
associated with increased hospitalizations for heart failure.  
She otherwise denied salt indiscretions and was compliant with 
her medications.  After discussion with her nephrologist, 
erythropoetin was discontinued, and she subsequently restarted 
her home oral diuretics with torsemide 100mg daily and 
metolazone 2.5mg QMWF.  She has close followup with her PCP and 
cardiologist to help titrate her diuretics.

2. ACUTE ON CHRONIC KIDNEY DISEASE: She has likely diabetic and 
hypertensive nephropathy and presented in stage III-VI CKD with 
a Cr of 2.4.  With diuresis, her creatinine slowly increased to 
a discharge level of 3.5, though the BUN remained stable from 
65-70.  Her creatinine failed to improve with easing of her 
diuretics, and so her home regimen was not intensified on 
discharge.  She will have electrolytes checked a few days 
following discharge.

3. CORONARY ARTERY DISEASE:  She has a history of severe 
coronary artery disease, and presented with an episode of 
substernal chest pain accompanying her dyspnea.  Her EKG was 
largely unchanged from prior.  Her cardiac troponin was 
initially less than assay, but then rose to 0.16 without further 
elevation, likely due to renal disease.  She had no further 
chest pain and no new wall motion abnormalities were seen on 
TTE, so ongoing ischemia was not suspected.

4. MITRAL VALVE VEGETATION: An echodensity was seen on the 
mitral valve on her ___ TTE.  Given her history of 
osteomyelitis, endocarditis was suspected and she was started 
empirically on vancomycin. ID was consulted.  Though her 
inflammatory markers were elevated, she had no fevers or 
peripheral sequelae of endocarditis, and so the suspicion of 
endocarditis fell.  Antibiotics were stopped and she remained 
afebrile and asymptomatic.  Blood cultures were negative.  A TEE 
was not pursued.  On further review of echo images, it is 
unclear if this density is new.

5. HYPERTENSION:  She presented with systolic blood pressures to 
the 160s-170s.  Her metoprolol was switched to labetalol for 
enhanced blood pressure control, which was uptitrated to maximal 
400mg BID.  Her pressures improved to about 140s systolic, 
requiring intermittent hydralazine.  Her labetalol was decreased 
to 200mg BID on discharge due to orthostasis.  She continued 
amlodipine and losartan.  She is at high risk for sleep apnea 
which also may be contributing to her hypertension, and she 
would benefit from outpatient testing.

6. ORTHOSTATIC HYPOTENSION:  She had asymptomatic orthostatic 
hypotension for the last few days of admission, which was felt 
to be related to aggressive diuresis, aggressive beta blockade, 
or autonomic dysfunction from diabetes.  Her labetalol was 
decreased to 200mg BID.  She was ambulating around the floor 
without difficulty, and was discharged with close followup.

INACTIVE ISSUES:
7. DIABETES MELLITUS, TYPE II:  She was continued on her home 
lantus/humalog sliding scale with good control.  Continued 
neurontin for neuropathy, and reglan for gastroparesis.
8. ANEMIA: Her hematocrit remained in the low ___.  
Erythropoetin was discontinued though she remained on iron 
supplementation.
9. HYPERPARATHYROIDISM: PTH mildly elevated at 72 this ___. 
Remained on calcium carbonate for calcium supplementation and 
phosphate binding.
10. DEPRESSION: continued sertraline
11. GERD: continued omeprazole
12. HYPERLIPIDEMIA: continued atorvastatin
13. LEFT ANKLE OSTEOMYELITIS:  No clinical evidence of ongoing 
infection with normal WBC count and a lack of fevers.  Continued 
dilaudid for pain control.

PENDING TESTS AT DISCHARGE: NONE

TRANSITIONAL CARE ISSUES:
-___ clinic followup
-obstructive sleep apnea testing
 
Medications on Admission:
Torsemide 100 mg daily
Losartan 100 mg daily
Isosorbide Mononitrate SR 120 mg BID
Omeprazole 20 mg BID
Lantus 22 units qhs
Metolazone 2.5 mg qMWF
Lorazepam 1 mg qid prn anxiety
Amlodipine 10 mg daily
Metoprolol Succinate 100 mg daily
MVI 1 tab daily
Metoclopramide 5 mg QID before meals and bedtime
Ferrous Gluconate 324 mg daily
ASA 325 mg daily
Nitroglycerin SL prn
Insulin lispro sliding scale
Sertraline 100 mg daily
Neurontin 300 mg TID
Lipitor 80 mg daily
Dilaudid 2mg BID
 
Discharge Medications:
1. torsemide 100 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
2. losartan 100 mg Tablet Sig: One (1) Tablet PO once a day.  
3. isosorbide mononitrate 120 mg Tablet Extended Release 24 hr 
Sig: One (1) Tablet Extended Release 24 hr PO twice a day.  
4. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) 
Capsule, Delayed Release(E.C.) PO BID (2 times a day).  
5. Lantus 100 unit/mL Solution Sig: ___ (22) units 
Subcutaneous at bedtime.  
6. metolazone 2.5 mg Tablet Sig: One (1) Tablet PO every MWF: 
please take a half-hour prior to torsemide.  
7. lorazepam 1 mg Tablet Sig: One (1) Tablet PO four times a day 
as needed for anxiety.  
8. amlodipine 10 mg Tablet Sig: One (1) Tablet PO once a day.  
9. labetalol 200 mg Tablet Sig: One (1) Tablet PO twice a day.
Disp:*60 Tablet(s)* Refills:*2*
10. multivitamin     Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
11. metoclopramide 5 mg Tablet Sig: One (1) Tablet PO with meals 
and at bedtime.  
12. ferrous gluconate 325 mg (37.5 mg Iron) Tablet Sig: One (1) 
Tablet PO DAILY (Daily).  
13. aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  

14. nitroglycerin 0.4 mg Tablet, Sublingual Sig: One (1) tab 
Sublingual PRN: may repeat every 5 minutes for chest pain, up to 
three doses.  ___ call MD if pain does not resolve.  
15. Humalog  Subcutaneous
16. sertraline 100 mg Tablet Sig: One (1) Tablet PO once a day.  

17. gabapentin 300 mg Capsule Sig: One (1) Capsule PO every 
eight (8) hours.  
18. atorvastatin 80 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
19. calcium carbonate 200 mg calcium (500 mg) Tablet, Chewable 
Sig: One (1) Tablet, Chewable PO TID (3 times a day).  
20. hydromorphone 2 mg Tablet Sig: One (1) Tablet PO twice a day 
as needed for pain.  
21. Outpatient Lab Work
please draw Chem10 on ___ and fax to the 
following offices:
Dr. ___ ___ Dr. ___ ___ 
Dr. ___ ___

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Acute on chronic diastolic heart failure exacerbation
diabetes mellitus
hypertension
hyperlipidemia
coronary artery disease
chronic kidney disease

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

You were admitted to ___ to treat an exacerbation of your 
congestive heart failure that we suspect was due to the 
medication Procrit that you started a few months ago.  We were 
able to slowly remove fluid from your lungs and legs with 
intravenous diuretics with resolution of your symptoms. We will 
be sending you home on the same diuretic regimen of torsemide 
100mg daily and metolazone 2.5mg every MWF.  Your procrit was 
stopped.

An echocardiogram showed a possible growth on one of your heart 
valves.  Consultation with the infectious disease doctors was 
___, and they did not think this was an infection called 
endocarditis.

It is extremely important that you weigh yourself every day.  
Please call your doctor if your weight goes up more than 3lb.  
Also, please avoid salty foods as this will help prevent further 
exacerbations and long hospital stays!

The following changes were made to your medications:
1. STOP PROCRIT
2. STOP metoprolol succinate
3. START LABETALOL 400mg twice a day to help control your blood 
pressure

It was a pleasure taking care of you, ___
 
___ Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=15521468-DS-24 | hadm_id=27410692

 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
Bactrim / Nafcillin / Lisinopril / difficult intubation requires 
LMA
 
Attending: ___.
 
Chief Complaint:
gangrene of right long finger
 
Major Surgical or Invasive Procedure:
___ - right long finger amputation

 
History of Present Illness:
___ h/o CAD s/p CABG x4, multiple cardiac stents, ESRD on PD, 
DM2, LLE osteomyelitis and gangrene of multiple digits of the 
right hand s/p right ___ finger amputation on ___ presenting 
with painful right ___ digit. Patient states she began 
experiencing severe pain in the ___ digit of the right hand 
approximately 3 days ago. She describes sharp, constant ___ 
pain. The finger has become increasingly swollen and 
erythematous, with the distal portion of the finger now black 
and necrotic. The finger had previously had purple discoloration 
at the tip but was not necrotic on discharge on ___. She 
endorses nausea over the last two days, but denies fever, 
chills, diarrhea, constipation or other associated symptoms.
 
Past Medical History:
PMH: CAD s/p CABG and multiple cath/stents, DM2 c/b retinopathy 
and neuropathy, HTN, HL, dCHF, ESRD on PD, obesity, LLE charcot 
ankle c/b osteomyelitis ___ s/p debridement, dieulafoy's lesion 
c/b massive GI bleed

PSH: CABG x5v ___, PD catheter placement 

 
Social History:
___
Family History:
significant for CAD
 
Physical Exam:
Vital Signs: Temp: 98.2 RR: 20 Pulse: 76 BP: 107/61  
Neuro/Psych: Oriented x3, Affect Normal, NAD. 
Neck: No masses, Trachea midline, Thyroid normal size,
non-tender, no masses or nodules, No right carotid bruit, No 
left
carotid bruit. 
Heart: Regular rate and rhythm. 
Lungs: Clear, Normal respiratory effort. 
Gastrointestinal: Non distended, No masses, Guarding or rebound,
No hepatosplenomegally, No hernia, No AAA. 
Extremities: RUE: ___ digit amp site, well healin sutures in
place, ___ digit black, necrotic at distal tip, ___ digit
swollen, TTP, distal segment black and necrotic 
 
Pulse Exam (P=Palpation, D=Dopplerable, N=None)
RUE Radial: D. Ulnar: D. 
LUE Radial: D. Ulnar: D. 
 
Pertinent Results:
___ 04:20PM   GLUCOSE-101* UREA N-67* CREAT-8.4*# 
SODIUM-133 POTASSIUM-5.2* CHLORIDE-89* TOTAL CO2-26 ANION 
GAP-23*
___ 04:20PM   estGFR-Using this
___ 04:20PM   CALCIUM-9.5 PHOSPHATE-6.5*# MAGNESIUM-2.1
___ 04:20PM   %HbA1c-6.0* eAG-126*
___ 04:20PM   WBC-15.9* RBC-3.12* HGB-9.6* HCT-30.3* 
MCV-97# MCH-30.9 MCHC-31.8 RDW-16.8*
___ 04:20PM   PLT COUNT-629*#
___ 04:20PM   ___ PTT-34.6 ___

Chemistries 

___ 04:20PM BLOOD Glucose-101* UreaN-67* Creat-8.4*# Na-133 
K-5.2* Cl-89* HCO3-26 AnGap-23*
___ 08:20AM BLOOD Glucose-127* UreaN-61* Creat-8.5* Na-130* 
K-4.5 Cl-87* HCO3-26 AnGap-22*
___ 07:30AM BLOOD Glucose-104* UreaN-56* Creat-8.0* Na-129* 
K-4.5 Cl-86* HCO3-24 AnGap-24*
___ 03:19AM BLOOD Glucose-127* UreaN-50* Creat-7.8* Na-129* 
K-4.3 Cl-86* HCO3-25 AnGap-22*
___ 07:25AM BLOOD Glucose-168* UreaN-46* Creat-7.4* Na-129* 
K-3.9 Cl-86* HCO3-27 AnGap-20
___ 07:57AM BLOOD Glucose-119* UreaN-40* Creat-7.1* Na-129* 
K-3.5 Cl-88* HCO3-29 AnGap-16
___ 07:46AM BLOOD Glucose-117* UreaN-38* Creat-7.3* Na-128* 
K-3.6 Cl-87* HCO3-25 AnGap-20
___ 04:00AM BLOOD Glucose-105* UreaN-39* Creat-7.3* Na-130* 
K-3.9 Cl-92* HCO3-25 AnGap-17

CBCs

___ 04:20PM BLOOD WBC-15.9* RBC-3.12* Hgb-9.6* Hct-30.3* 
MCV-97# MCH-30.9 MCHC-31.8 RDW-16.8* Plt ___
___ 08:20AM BLOOD WBC-16.3* RBC-2.90* Hgb-9.1* Hct-28.6* 
MCV-99* MCH-31.3 MCHC-31.7 RDW-17.0* Plt ___
___ 07:30AM BLOOD WBC-13.9* Hct-29.4* Plt ___
___ 03:19AM BLOOD WBC-16.4* RBC-2.97* Hgb-8.9* Hct-29.0* 
MCV-98 MCH-30.0 MCHC-30.8* RDW-16.9* Plt ___
___ 07:25AM BLOOD WBC-17.4* RBC-2.97* Hgb-8.8* Hct-28.5* 
MCV-96 MCH-29.7 MCHC-30.9* RDW-16.5* Plt ___
___ 07:57AM BLOOD WBC-16.4* RBC-3.00* Hgb-9.2* Hct-29.2* 
MCV-97 MCH-30.7 MCHC-31.7 RDW-16.6* Plt ___
___ 07:46AM BLOOD WBC-18.0* RBC-2.86* Hgb-8.8* Hct-27.5* 
MCV-96 MCH-30.8 MCHC-32.0 RDW-16.6* Plt ___
___ 04:00AM BLOOD WBC-16.9* RBC-2.95* Hgb-9.0* Hct-28.4* 
MCV-96 MCH-30.4 MCHC-31.5 RDW-16.4* Plt ___

LUE U/S ___ for LUE swelling: no DVT
 
Brief Hospital Course:
___ admitted on ___ due to worsening right long finger 
gangrene.  She empirically was started on broad spectrum 
antibiotics.  She was also started on a heparin drip.  Her 
hospital course was realtively benign.  On ___ she developed 
LUE swelling, but an U/S showed no DVT.  As such, warm 
compresses and limb elevation were applied to the affected area 
with good effect.

By ___, it was clear that the demarcation had completed.  As 
such, we amputated her right long finger all the way to the 
metacarpophalangeal joint space.  She tolerated the conscious 
sedation and procedure well, and was shortly thereafter brought 
to the PACU and subsequently to the floor.  Her diet was 
advanced, and she had good pain control.  We resumed her heparin 
drip and commenced warfarin therapy.  She was not a candidate 
for enoxaparin, and so we had to keep her here until she became 
therapeutic on warfarin.  Once she achieved her goal INR, she 
was discharged home in stable condition with instructions to 
follow up with Dr. ___ as an outpatient in 2 weeks time.  
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 325 mg PO DAILY 
2. Ezetimibe 10 mg PO DAILY 
3. Ferrous GLUCONATE 324 mg PO DAILY 
4. Gabapentin 100 mg PO BID 
5. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN pain 
6. Glargine 12 Units Breakfast
Glargine 36 Units Bedtime
Insulin SC Sliding Scale using HUM Insulin
7. Lorazepam 1 mg PO DAILY:PRN anxiety 
8. Metoclopramide 5 mg PO QIDACHS 
9. Midodrine 10 mg PO BID 
10. Nephrocaps 1 CAP PO DAILY 
11. Omeprazole 40 mg PO DAILY 
12. Rosuvastatin Calcium 40 mg PO DAILY 
13. Sertraline 100 mg PO DAILY 
14. sevelamer CARBONATE 2400 mg PO TID W/MEALS 
15. Minocycline 100 mg PO BID 
16. Docusate Sodium 100 mg PO BID 
17. Nystatin Cream 1 Appl TP BID 
18. Senna 1 TAB PO BID:PRN constipation 
19. Gentamicin 0.1% Cream 1 Appl TP TID 
20. Epoetin Alfa 30,000 U SC EVERY 2 WEEKS 

 
Discharge Medications:
1. Aspirin 325 mg PO DAILY 
2. Docusate Sodium 100 mg PO BID 
3. Epoetin Alfa 30,000 U SC EVERY 2 WEEKS 
4. Ezetimibe 10 mg PO DAILY 
5. Ferrous GLUCONATE 324 mg PO DAILY 
6. Gabapentin 100 mg PO BID 
7. Gentamicin 0.1% Cream 1 Appl TP TID 
8. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN pain 
RX *hydromorphone 2 mg ___ tablet(s) by mouth every ___ hours 
Disp #*40 Tablet Refills:*0
9. Lorazepam 1 mg PO DAILY:PRN anxiety 
10. Metoclopramide 5 mg PO QIDACHS 
11. Midodrine 10 mg PO BID 
12. Nephrocaps 1 CAP PO DAILY 
13. Nystatin Cream 1 Appl TP BID 
14. Omeprazole 40 mg PO DAILY 
15. Rosuvastatin Calcium 40 mg PO DAILY 
16. Senna 1 TAB PO BID:PRN constipation 
17. Sertraline 100 mg PO DAILY 
18. sevelamer CARBONATE 2400 mg PO TID W/MEALS 
19. Amoxicillin-Clavulanic Acid ___ mg PO Q24H Duration: 5 Days 
RX *amoxicillin-pot clavulanate 500 mg-125 mg 1 tablet(s) by 
mouth every 24 hours Disp #*5 Tablet Refills:*0
20. Bisacodyl 10 mg PO BID 
21. Acetaminophen 650 mg PO Q6H pain 
22. Glargine 12 Units Breakfast
Glargine 36 Units Bedtime
Insulin SC Sliding Scale using HUM Insulin
23. Warfarin 3 mg PO DAILY16 
  
RX *warfarin 3 mg 1 tablet(s) by mouth daily at 4 pm Disp #*30 
Tablet Refills:*0

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
wet gangrene of right long finger
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
Mrs. ___, you were admitted for a worsening infection in 
your right long finger, which we had to amputate.  You recovered 
from this procedure very nicely and are ready to go home.  
Please continue to take your warfarin and be sure to follow up 
with your primary care provider for INR checks.  Taking care of 
you was our pleasure; we look forward to seeing you as an 
outpatient.

Weigh yourself every morning, call MD if weight goes up more 
than 3 lbs.
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=15521468-DS-13 | hadm_id=28386167

 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Bactrim
 
Attending: ___.
 
Chief Complaint:
Abnormal labs  

 
Major Surgical or Invasive Procedure:
trans-esophageal echocardiogram

 
History of Present Illness:
___ year old female with CAD s/p CABG, poorly controlled IDDM, 
presenting for evaluation of elevated ESR and WBC. The patient 
has a complicated cardiac history (see below) and was found to 
have a new holosystolic murmur on an admission for 
gastroenteritis in early ___. Echocardiogram at that time 
did not reveal any concerning lesions, and the patient was 
hydrated and discharged. She was re-admitted ___ for CHF 
exacerbation and was successfully diuresed.  
.  
During the first ___ admission, she was found to have a UTI and 
was treated with 3 days of Bactrim. She continued to have low 
grade fevers and her PCP gave her an additional 7 days of 
Bactrim treatment. During the last hospitalization, her low 
grade fevers persisted and she was treated with a 7 day course 
of Ciprofloxacin after UCx demonstrated coag neg staph--last 
dose yesterday. Her fevers resolved early during the cipro 
course and she has been afebrile since.  
.  
Her PCP wanted repeat blood work for evaluation after treatment 
of the UTI. Her WBC was elevated, yet felt well. Her 
cardiologist was contacted and the patient was admitted for TEE 
to rule out endocarditis.  
.  
In the ED, initial vitals were 98.3, 137//63, 70, 16, 98% RA. 
Blood cultures taken, but given lack of fever and no clear 
diagnosis, no antibiotics were started. She was admitted for 
TEE.  

 
Past Medical History:
 
- DM2 (___) c/b neuropathy/retinopathy, HbA1C 14.5 in ___,  
- hypertension  
- dyslipidemia  
- CAD - s/p CABG ___ (___->LAD, SVG-PDA, SVG->OM1, SVG->OM2, 
SVG-  
>D1), c/b sternal wound infection, with all saphenous vein 
grafts  
known to be occluded and multiple PCI/stents to the LCx and OM1  

with recurrent occlusion and eventual decision for medical  
management (good collateralization)  
-Repeat catheterization on ___ showing all vein grafts  
occluded and 80% mid circumflex stenosis, and 70% OM1 stenosis  
status post 2.5-mm stents;  
-Catheterization on ___: done for recurrent angina,  
occluded proximal OM with in-stent restenosis, status post PTCA  

and brachytherapy.  
-Recurrent symptoms on ___ showing 99% ISR of OM1 status  
post Cypher DES, and 80% ISR of mid circumflex status post CES,  

-Catheterization ___ for recurrent symptoms showing 70%  
diffuse lesion distal to the stent in the proximal OM, status  
post 2.5 x 18 mm drug-eluting stent; most recent cardiac  
catheterization as described below.  
- left great toe ulcer since ___.  
- depression.  

 
Social History:
___
Family History:
family history of premature coronary artery disease (father, MI 
___, no h/o sudden death
 
Physical Exam:
T 98.0 BP 120/76 HR 78 rr 16
Gen: obese female asleep, easily woken, but falls asleep during 
inteview. Oriented x3. Mood, affect appropriate.  
HEENT: OP clear  
Neck: Unable to visualize JVP  
CV: RRR, III/VI SM at ___, nonradiating  
Chest: CTAB  
Abd: Soft, NTND. No HSM or tenderness. obese  
Ext: No c/c/e. No femoral bruits. No evidence of distal emboli  
 
 
Pertinent Results:
___ 03:45PM   ___ PTT-29.2 ___
___ 09:56AM   ___
___ 04:45AM URINE  HOURS-RANDOM
___ 04:45AM URINE  UHOLD-HOLD
___ 04:45AM URINE  COLOR-Yellow APPEAR-Clear SP ___
___ 04:45AM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-TR 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 
LEUK-NEG
___ 04:45AM URINE  RBC-<1 WBC-<1 BACTERIA-NONE YEAST-NONE 
EPI-<1
___ 04:45AM URINE  MUCOUS-RARE
___ 01:33AM   LACTATE-0.8
___ 12:25AM   estGFR-Using this
___ 12:25AM   IRON-30
___ 12:25AM   calTIBC-376 FERRITIN-37 TRF-289
___ 12:25AM   WBC-13.5* RBC-3.87* HGB-9.7* HCT-30.5* 
MCV-79* MCH-25.1* MCHC-31.8 RDW-14.6
___ 12:25AM   NEUTS-71.5* BANDS-0 ___ MONOS-3.7 
EOS-2.2 BASOS-0.4
___ 12:25AM   HYPOCHROM-2+ ANISOCYT-OCCASIONAL 
POIKILOCY-OCCASIONAL MACROCYT-NORMAL MICROCYT-NORMAL 
POLYCHROM-NORMAL OVALOCYT-OCCASIONAL
___ 12:25AM   PLT COUNT-638*
___ 12:25AM   SED RATE-150*
 
Brief Hospital Course:
Hospital Course: ___ yo female with CAD s/p CABG, poorly 
controlled DM presenting for further evaluation of leukocytosis. 
 
.  
1. Leukocytosis: The patient has a low grade leukocytosis and 
elevated ESR in the setting of new murmur. The patient was 
admitted for a TEE which was performed and was negative. She 
will follow up with her PCP, ___ (___) 
for further evaluation of her leukocytosis. Dr. ___ was 
contacted and told the results of the patient's TEE and has 
scheduled follow-up for ___.
.  
2. CAD/CHF: The patient was continued on her outpatient meds, 
including aspirin, plavix, statin, beta blocker, ace, lasix. 
.  
3. DM: The patient was continued on her home regimen of glargine 
45 u qhs and SSI. She was encouraged to follow-up with ___ on 
discharge.
.  
4. Hyperkalemia: The patient was taken off her potassium 
repletion. She was continued on her home lisinopril and will 
have her lytes followed up by her PCP.
.  
5. Hypertension: The patient was continued on her outpatient 
regimen.  
.  
6. Hyperlipidemia: The patient was continued on her zetia and 
statin.  
.  
7. FEN: The patient was NPO and then placed on a cardiac diet.
.  
9. PPx: The patient was continued on heparin sc. 
.  
10. Code: FULL CODE.  

 
Medications on Admission:
 
1. Norvasc 10 mg a day.  
2. Aspirin 325 mg once daily.  
3. Plavix 75 mg once daily.  
4. Zetia 10 mg once daily.  
5. Lasix 40 mg once daily.  
6. Neurontin 300 mg three times a day.  
7. Imdur 30 mg daily.  
8. Zestril 20 mg daily.  
9. Lopressor 50 mg b.i.d.  
10. Sublingual nitroglycerin.  
11. Potassium 20 mEq.  
12. Zoloft 50 mg daily.  

 
Discharge Medications:
1. Clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
2. Lisinopril 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
3. Sertraline 50 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
4. Gabapentin 300 mg Capsule Sig: One (1) Capsule PO Q8H (every 
8 hours).  
5. Furosemide 40 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
6. Ezetimibe 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  

7. Amlodipine 5 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).  

8. Aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  
9. Isosorbide Mononitrate 30 mg Tablet Sustained Release 24 hr 
Sig: One (1) Tablet Sustained Release 24 hr PO DAILY (Daily).  
10. Metoprolol Tartrate 50 mg Tablet Sig: One (1) Tablet PO BID 
(2 times a day).  
11. Insulin Regular Human 300 unit/3 mL Insulin Pen Sig: PER 
HOME SLIDING SCALE PER HOME SLIDING SCALE Subcutaneous four 
times a day: PER HOME SLIDING SCALE.  
12. Insulin Glargine 300 unit/3 mL Insulin Pen Sig: ___ 
(45) units Subcutaneous at bedtime.  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
leukocytosis

 
Discharge Condition:
Stable. The patient is afebrile and asymptomatic.

 
Discharge Instructions:
Take all medications as prescribed.

Follow-up with your primary care physician as below.

Please call your doctor or return to the emergency room if you 
experience:
--fever or chills
--chest pain
--shortness of breath
--abdominal pain
--joint pain
--any other symptom that concerns you
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=15521468-DS-23 | hadm_id=28492994

 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
Bactrim / Nafcillin / Lisinopril / difficult intubation requires 
LMA
 
Attending: ___.
 
Chief Complaint:
right ___ finger gangrene
 
Major Surgical or Invasive Procedure:
R ___ digit amputation

 
History of Present Illness:
___ w/ h/o CAD s/p CABG x4, multiple cardiac stents, ESRD on PD, 
DM2, and LLE osteomyelitis with gangrene of the ___ finger of 
the right hand secondary to atheroembolic disease. 
 
Past Medical History:
PMH: CAD s/p CABG and multiple cath/stents, DM2 c/b retinopathy 
and neuropathy, HTN, HL, dCHF, ESRD on PD, obesity, LLE charcot 
ankle c/b osteomyelitis ___ s/p debridement, dieulafoy's lesion 
c/b massive GI bleed

PSH: CABG x5v ___, PD catheter placement 

 
Social History:
___
Family History:
significant for CAD
 
Physical Exam:
Vitals: 98.7 78 102/51 18 100 RA
Gen: NAD, AOx3
CV: RRR, no murmurs
Pulm: CTAB, unlabored
Abd: soft, nontender, nondistended, pd cath in place
Ext: WWP lower extremities, minimal edema. BUE faintly palpable
radial pulses  RUE: ___ digit amp site CDI, no erythema, ___ 
digit with ulceration on lateral aspect and ___ and ___ digit w/ 
dark purple discoloration at the distal aspects and slow 
capillary refill, tender to palpation
 
Pertinent Results:
___ 10:38AM   K+-3.8
 
Brief Hospital Course:
Patient was admitted to ___ for an elective right hand ___ 
digit amputation. The procedure was uncomplicated, please see 
the dictated operative report for details of the procedure. She 
was transferred from the PACU in good contion and admitted to 
the floor for observation. 

A nephrology consult was placed post-operatively for management 
of her peritoneal dialysis. She underwent peritoneal dialysis on 
the floor without complication. On POD 1 she was ambulatory, 
tolerating a regular diet and her pain was well controlled on 
oral pain medications. The wound was examined and was clean, dry 
and intact with no evidence of erythema. She was discharged home 
on POD 1 in good condition. 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Rosuvastatin Calcium 40 mg PO DAILY 
2. sevelamer CARBONATE 2400 mg PO TID W/MEALS 
3. Ezetimibe 10 mg PO DAILY 
4. Ferrous GLUCONATE 324 mg PO DAILY 
5. Lorazepam 1 mg PO DAILY:PRN anxiety 
6. Nystatin Cream 1 Appl TP BID 
7. Midodrine 10 mg PO BID 
8. Sertraline 100 mg PO DAILY 
9. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN pain 
10. Warfarin 2 mg PO DAILY16 
Please start this dose on ___. Follow INR closely while on 
coumadin and adjust dose as needed 
11. Senna 1 TAB PO BID:PRN constipation 
12. Glargine 12 Units Breakfast
Glargine 36 Units Bedtime
Insulin SC Sliding Scale using HUM Insulin
13. Nephrocaps 1 CAP PO DAILY 
14. Aspirin 325 mg PO DAILY 
15. Gabapentin 100 mg PO BID 
16. Omeprazole 40 mg PO DAILY 
17. Metoclopramide 5 mg PO QIDACHS 
18. Docusate Sodium 100 mg PO BID 
19. Gentamicin 0.1% Cream 1 Appl TP TID 

 
Discharge Medications:
1. Aspirin 325 mg PO DAILY 
2. Ezetimibe 10 mg PO DAILY 
3. Ferrous GLUCONATE 324 mg PO DAILY 
4. Gabapentin 100 mg PO BID 
5. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN pain 
RX *hydromorphone 2 mg ___ tablet(s) by mouth every four (4) 
hours Disp #*40 Tablet Refills:*0
6. Glargine 12 Units Breakfast
Glargine 36 Units Bedtime
Insulin SC Sliding Scale using HUM Insulin
7. Lorazepam 1 mg PO DAILY:PRN anxiety 
8. Metoclopramide 5 mg PO QIDACHS 
9. Midodrine 10 mg PO BID 
10. Nephrocaps 1 CAP PO DAILY 
11. Omeprazole 40 mg PO DAILY 
12. Rosuvastatin Calcium 40 mg PO DAILY 
13. Sertraline 100 mg PO DAILY 
14. sevelamer CARBONATE 2400 mg PO TID W/MEALS 
15. Minocycline 100 mg PO BID Duration: 7 Days 
RX *minocycline [Dynacin] 100 mg 1 tablet(s) by mouth twice a 
day Disp #*13 Capsule Refills:*0
16. Docusate Sodium 100 mg PO BID 
17. Nystatin Cream 1 Appl TP BID 
18. Senna 1 TAB PO BID:PRN constipation 
19. Warfarin 2 mg PO DAILY16 
20. Gentamicin 0.1% Cream 1 Appl TP TID 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
right hand ___ digit gangrene

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
MEDICATIONS: 
Take your medications as prescribed in your discharge 
Take pain medication as needed / as prescribed
Remember that narcotic pain medication can be constipating.  
Increase your fiber intake 
ACTIVITY: 
You should avoid using your right hand as much as possible
You should keep this amputation site elevated when ever 
possible. 
No heavy lifting greater than 20 pounds for the next ___ days. 
BATHING/SHOWERING: 
You may shower tomorrow
No tub baths or pools / do not soak your foot for 4 weeks from 
your date of surgery 
WOUND CARE:
Your sutures will be removed at your follow up appointment in 
3 weeks.
When the sutures are removed the doctor may or may not place 
pieces of tape called steri-strips over the incision. These will 
stay on about a week and you may shower with them on. If these 
do not fall off after 10 days, you may peel them off with warm 
water and soap in the shower.
CAUTIONS:
If you smoke, please make every attempt to quit.  Your primary 
care physician can help with this.  Smoking causes narrowing of 
your blood vessels which in turn decreases circulation.  
DIET:
Low fat, low cholesterol / if you are diabetic  follow your 
dietary restrictions as before 
CALL THE OFFICE FOR: ___
Bleeding, redness of, or drainage from your hand wound
New pain, numbness or discoloration of the skin on the 
effected hand
Fever greater than 101 degrees, chills, increased redness, or 
pus draining from the incision site. 

Weigh yourself every morning, call MD if weight goes up more 
than 3 lbs.
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=15521468-DS-20 | hadm_id=28794243

 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Bactrim / Nafcillin / Lisinopril
 
Attending: ___
 
Chief Complaint:
Chest pain
 
Major Surgical or Invasive Procedure:
none
 
History of Present Illness:
___ woman with a history of coronary artery disease and 
CABG surgery at age ___, heart failure with preserved LVEF on 
home oxygen at 2L, DM, CKD, and chronic anemia who presents with 
worsening shortness of breath and left-sided chest pain. 
Shortness of breath has worsened since ___ ___ last night with 
increasing oxygen requirement up to 3 L. Chest pain started at 1 
a.m. constant, nonradiating.
  
In the ED, initial vitals were 97.4 71 115/55 18 97% 3L Nasal 
Cannula 
Labs  significant for a HCT of 19.9. Troponin of 0.29.  
EKG: showed TWI I, AVL, V5-6, no change from prior. Chest x-ray 
was c/w fluid overload. She was treated with Aspirin, SL nitro x 
1, morphine x 4mg. She was transfused 1 unit of pRBCs. 
  
On arrival to the floor, her chest pain has improved, currently 
___ down from ___. She also feels less short of breath. The 
patient weights 224.9lbs which is about 15 pounds above her 
reported dry weight of 210 pounds.  

 
Past Medical History:
-CAD s/p CABG ___ (LIMA to LAD, SVG to PDA, OM1, OM2, D1) 
Cath ___ all SVG occluded, stent to Lcx,Om1. Cath ___ ISR, 
brachytherapy. ___ stents to OM1, LCx. ___ OM occluded.
-DMII c/b retinopathy, neuropathy
-HTN
-HL
-dCHF EF 55%
-Chronic renal failure
-Obesity
-charcot ankle on left with osteomyelitis ___
-Intestinal Dieulafoy's (Hemorrhagic) Lesion
 
Social History:
___
Family History:
She reports her mother developed lung cancer, she was a smoker. 
She had a grandmother and an aunt who had breast cancer, 
grandmother was diagnosed with breast cancer in her ___ and her 
aunt was in her ___. There is no other family history of cancer.
 
Physical Exam:
Physical Exam on admission:
VS: 140/71, 72, 16, 92% 3L
GENERAL: WDWN in NAD. Oriented x3. Mood, affect appropriate. 
Husband at bedside.  
HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were 
pink, no pallor or cyanosis of the oral mucosa. No xanthalesma.  

NECK: Supple  
CARDIAC: RR, normal S1, S2. ___ systolic murmur. No thrills, 
lifts. No S3 or S4.  
LUNGS: Decreased breath sounds at bases bilaterally. No 
accessory muscle use. 
ABDOMEN: Soft, Protuberant Abdomen. Nontender. No HSM. Abd aorta 
not enlarged by palpation. No abdominial bruits.  
EXTREMITIES: Left foot swollen but at baseline per patient. 
Trace edema to ankle. Open wound on left leg. 
RECTAL: Guiac negative in the ED 
PULSES:  
Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ ___ 2+  
Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ ___ 2+ 

Physical Exam on discharge:
VS: 98.8/98.8, 126-173/69-76, 18, 92% 3L (Weight 97.2 kg)
GENERAL: NAD. Oriented x3. Mood, affect appropriate. Husband at 
bedside.  
HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were 
pink, no pallor or cyanosis of the oral mucosa. No xanthalesma.  

NECK: Supple  
CARDIAC: RR, normal S1, S2. ___ systolic murmur. No thrills, 
lifts. No S3 or S4.  
LUNGS: Decreased breath sounds at bases bilaterally, no crackles 
noted today. No accessory muscle use. 
ABDOMEN: Soft, Protuberant Abdomen. Nontender. No HSM. Abd aorta 
not enlarged by palpation. No abdominial bruits.  
EXTREMITIES: Left foot swollen but at baseline per patient. 
Trace edema to ankle. Open wound on left leg. 
RECTAL: Guiac negative in the ED 
PULSES:  
Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ ___ 2+  
Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ ___ 2+  
 
Pertinent Results:
Labs on admission:

___ 06:10PM BLOOD WBC-9.9 RBC-2.77* Hgb-8.1* Hct-23.9* 
MCV-87 MCH-29.1 MCHC-33.7 RDW-16.5* Plt ___
___ 06:25AM BLOOD Glucose-237* UreaN-102* Creat-3.8* Na-138 
K-5.1 Cl-96 HCO3-29 AnGap-18
___ 06:25AM BLOOD LD(LDH)-205 CK(CPK)-77
___ 06:10PM BLOOD ALT-16 AST-16 LD(LDH)-210 CK(CPK)-90 
AlkPhos-117* TotBili-0.6
___ 07:34AM BLOOD CK(CPK)-73
___ 06:25AM BLOOD CK-MB-4 ___
___ 06:25AM BLOOD cTropnT-0.29*
___ 10:32AM BLOOD cTropnT-0.28*
___ 06:10PM BLOOD CK-MB-5 cTropnT-0.36*
___ 07:34AM BLOOD CK-MB-3 cTropnT-0.32*
___ 07:34AM BLOOD TotProt-6.9 Calcium-8.8 Phos-5.4* Mg-2.6
___ 06:25AM BLOOD calTIBC-241* VitB12-1375* Folate-GREATER 
TH Hapto-363* Ferritn-374* TRF-185*
___ 07:34AM BLOOD C3-176 C4-49*
___ 07:34AM BLOOD HCV Ab-NEGATIVE

CXR ___:
IMPRESSION: Mild edema. Left basilar opacity could be due to 
edema, but 
infection, atelectasis or infarction are also possible. If there 
is any 
clinical concern for pulmonary embolus, CT of the chest should 
be obtained 

Labs on discharge:

___ 07:45AM BLOOD WBC-10.4 RBC-3.28* Hgb-9.6* Hct-27.5* 
MCV-84 MCH-29.3 MCHC-35.0 RDW-15.0 Plt ___
___ 07:20AM BLOOD Glucose-112* UreaN-96* Creat-3.7* Na-143 
K-4.4 Cl-99 HCO3-33* AnGap-15
___ 07:20AM BLOOD Calcium-9.4 Phos-5.7* Mg-2.___SSESSMENT AND PLAN: ___ woman with a history of 
coronary artery disease and CABG surgery at age ___, heart 
failure with preserved LVEF on home oxygen at 2L, DM, CKD, and 
chronic anemia who presents with worsening shortness of breath 
and left-sided chest pain.  
  
# Demand Ischemia:  Chest pain likely represented demand 
ischemia in the setting of anemia and volume overload. Chest 
pain quickly dissipated and her breathing improved once pt was 
given 3 units of pRBCs for her anemia and diuresed (-7 L over 
the hopsitalization) with a lasix drip.  Troponins were mildly 
elevated above baseline but in the setting of worsened renal 
function and anemia, this bump was most likely ___ demand 
ischemia and not ACS. We continue her home home meds of ASA, 
atorvastatin and labetalol.
  
# Acute on Chronic Diastolic Heart Failure: Pt was about 15 
pounds above dry weight on admission.  She diuresed well with a 
lasix gtt and home metolazone dose and was down 5.2 kg on 
dischaerge.  We did switch her back to her home diuretic regimen 
of torsemide 100 mg po and metolazone 2.5 mg daily the day 
before discharge.   

# Hypertension:  Pt remained hypertension during much of the 
admission with SBP's as high as the 170's.  We did incrwased her 
home labetalol dose to 400 mg bid with minimal improvement.  A 
main barrier to further BP control was that she remained 
orthostatic (80's/50's when standing) although was aymptomatic.  
We believe that the orthostasis may be related to her 
longstanding diabetes, as well as possible over-diuresis.  We 
sent the pt home on her normal blood pressure regimen, with 
instructions on managing her orthostasis.
  
# Anemia: Hct on admission was 19.  Pt was given 3 untis of 
pRBC's and had an appropriate hct increase.  She reamined stable 
in the ___ range for the rest of the hospitalization.  She has 
required multiple transfusions in the past. Prior hematology 
workup suggested it was secondary to AOCD/renal disease.  Iron 
studies on this admission also suggest that it is secondary to 
AOCD. She was previously on Procrit but this was stopped due to 
concern for exacerbating heart failure.  I spoke with Dr. ___ 
___ possibly restarting procit with a modest goal of ___ in 
an attempt to prevent further episodes of demand ischemia. 
  
# Acute on Chronic Kidney Disease: Cr remained in 3.6 -3.9 range 
during admission.  FEurea of 31 which was consistent with 
pre-renal etiology, likely from poor perfusion to kidneys from 
worsening CHF. She also has nephrotic range proteinuria which 
was also present in ___. This is most likely diabetic 
nephrosclerosis.  She will follow-up with her nephrologist Dr. 
___.
  
# Diabetes mellitus: Blood glucose well-controlled on Lantus 
from 20 qHS and humalog sliding scale.

 
Medications on Admission:
Amlodpine 10mg qPM
Atorvastatin 80mg qPM
Gabapentin 300mg TID
Hydromorphone 2mg BID PRN
Lantus 18u SC qhs
Humalog Sliding scale 
Isosorbide mononitrate ER 60mg daily
Labetatlol 200mg BID
Lorazepam 1mg PRN
Losartan 25mg daily
Metoclopramide 5mg PO QID
Metolazone 2.5mg on ___
Omeprazole 20mg PO BID
Sertraline 100mg PO Daily
Torsemide 100mg PO Daily
Aspirin 325mg PO Daily
Ferrous Gluconate 324mg PO daily
Magnesium 400mg PO daily
Centrum Silver once daily

 
Discharge Medications:
1. atorvastatin 80 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
2. amlodipine 5 mg Tablet Sig: Two (2) Tablet PO HS (at 
bedtime).  
3. gabapentin 300 mg Capsule Sig: One (1) Capsule PO Q24H (every 
24 hours).  
4. insulin lispro 100 unit/mL Solution Sig: One (1)  
Subcutaneous at bedtime: please take 18 units at bedtime.  
5. Humalog 100 unit/mL Solution Sig: One (1)  Subcutaneous three 
times a day: sliding scale.  
6. isosorbide mononitrate 60 mg Tablet Extended Release 24 hr 
Sig: One (1) Tablet Extended Release 24 hr PO DAILY (Daily).  
7. labetalol 200 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day).  
8. lorazepam 1 mg Tablet Sig: One (1) Tablet PO HS (at bedtime) 
as needed for anxiety.  
9. metoclopramide 10 mg Tablet Sig: 0.5 Tablet PO QIDACHS (4 
times a day (before meals and at bedtime)).  
10. losartan 25 mg Tablet Sig: One (1) Tablet PO once a day.  
11. metolazone 2.5 mg Tablet Sig: One (1) Tablet PO QMOWEFR: 
Take on ___ and ___.  
12. omeprazole 20 mg Tablet, Delayed Release (E.C.) Sig: One (1) 
Tablet, Delayed Release (E.C.) PO twice a day.  
13. sertraline 100 mg Tablet Sig: One (1) Tablet PO once a day.  

14. torsemide 100 mg Tablet Sig: One (1) Tablet PO once a day.  
15. aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  

16. ferrous gluconate 325 mg (37.5 mg iron) Tablet Sig: One (1) 
Tablet PO DAILY (Daily).  
17. magnesium oxide 400 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
18. Centrum Silver     Tablet Sig: One (1) Tablet PO once a day. 
 
19. Dilaudid 2 mg Tablet Sig: ___ Tablet PO twice a day as 
needed for pain.  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
CHF exacerbation
Anemia

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.

Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear ___,

___ was a pleasure taking care of you during your hospitalization 
here at ___.  You were admitted 
with worsening shortness of breath and chest pain.  You were 
also found to have severe anemia and around 15 extra pounds of 
fluid that had accumulated on your body.  We beleive that the 
extra fluid as well as your anemia likely caused you to have 
chest pain and a small amount of damage to your heart muscle.
   We gave you three units of blood to help correct the enemia 
and put you on a lasix drip that was successful in removing a 
large amount of fluid from your body.
   Your chest pain and shortness improved dramatically with the 
above therapy. Your blood pressure goes down significantly when 
you stand up, but you do not seem to have any symptomatic 
change. Please be careful when standing up, and give yourself 
time to equilibrate before walking. If you are dizzy while 
standing, please talk to your cardiologist about stopping one of 
your blood pressure medications.

You are now safe for discharge home.

MEDICATION CHANGES:
- Because of your worsening kidney function, please take 
gabapentin once a day instead of three times a day.
- Because of your worsening kidney function, you may be more 
susceptible to sedation from your Dilaudid (hydromorphone). 
Please be cautious when taking Dilaudid for pain in your foot.

Weigh yourself every morning, call MD if weight goes up more 
than 3 lbs.
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=15521468-DS-12 | hadm_id=29546679

 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Patient recorded as having No Known Allergies to Drugs
 
Attending: ___.
 
Chief Complaint:
dyspnea on exertion
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
The patient is a ___ year-old female with a history CAD s/p CABG 
(EF=50-55%), HTN, IDDM, hyperlipidemia, who presents for 
evaluation of new DOE, orthopnea, and ___ edema x 3d. Her 
symptoms began 3d ago, she denies CP, but notes +palpitations, 
increased abdominal girth and ___ edema, does not weigh herself 
daily, new orthopnea (usu sleeps at 30 degrees since CABG, now 
sleeping upright in chair x3d). DOE occurs with ambulation to 
bathroom, not at rest. She was seen by her cardiolgist on ___, 
without sx of heart failure, but noted to have new basal 
inferior AK on recent TTE.  
.  
Of note, pt recently d/c'd from ___ ___ for viral 
gastroenteritis, dehydration, found to have UTI (increased 
frequency). At that time she was noted to have new murmur, 
though TTE showed no vegetation, valvular abnormality, and 
normal EF. She was discharged on 3d course of bactrim. ~2wk 
after discharge, she notes fevers to 100.6 daily, last 
___, she saw her PCP, who obtained UA and started 7d 
course of bactrim for UTI (prior BI culture polymicrobial).  
.  
pt denies recent cp, no recent medication changes, 
non-compliance, dietary indiscretion. she does note a sensation 
of heart racing, ___ per day, starting during past hospital 
admission, typically with exertion, and when lying flat.  
In the ED, VS= 98.7 79 127/66 20 97%RA (89-95% per ED), her 
murmur was noted to be prominent, ___ SEM, EKG no ste/std, CE 
negative x 1, CXR c/w CHF, pt noted to hct ___, guaic 
negative, K=5.4. UA BCx drawn, given lasix 40mg iv x 1. Pt 
admitted for workup of CHF and ?endocarditis.  

 
Past Medical History:
- DM2 (___) c/b neuropathy/retinopathy, HbA1C 14.5 in ___,  
- hypertension  
- dyslipidemia  
- CAD - s/p CABG ___ (LIMA->LAD, SVG-PDA, SVG->OM1, SVG->OM2, 
SVG->D1), c/b sternal wound infection, with all saphenous vein 
grafts known to be occluded and multiple PCI/stents to the LCx 
and OM1 with recurrent occlusion and eventual decision for 
medical management (good collateralization)  
-Repeat catheterization on ___ showing all vein grafts  
occluded and 80% mid circumflex stenosis, and 70% OM1 stenosis  
status post 2.5-mm stents;  
-Catheterization on ___: done for recurrent angina,  
occluded proximal OM with in-stent restenosis, status post PTCA  

and brachytherapy.  
-Recurrent symptoms on ___ showing 99% ISR of OM1 status  
post Cypher DES, and 80% ISR of mid circumflex status post CES,  

-Catheterization ___ for recurrent symptoms showing 70%  
diffuse lesion distal to the stent in the proximal OM, status  
post 2.5 x 18 mm drug-eluting stent; most recent cardiac  
catheterization as described below.  
- left great toe ulcer since ___.  
- depression.  
 
Social History:
___
Family History:
There is +family history of premature coronary artery disease 
(father, MI ___, no h/o sudden death. 
 
Physical Exam:
VS - 98.0 115/57 70 16 94%RA 113 kg (UOP 800cc per pt)  
Gen: WDWN middle aged female in NAD. Oriented x3. Mood, affect 
appropriate.  
HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were 
pink, no pallor or cyanosis of the oral mucosa. No xanthalesma.  

Neck: Supple with JVP of 8 cm.  
CV: PMI located in ___ intercostal space, midclavicular line. 
RR, normal S1, S2. No r/g. No thrills, lifts. No S3 or S4. ___ 
SEM @ LSB  
Chest: No chest wall deformities, scoliosis or kyphosis. Resp 
were unlabored, no accessory muscle use. bilateral basilar 
rales, no wheezes or rhonchi.  
Abd: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by 
palpation. No abdominial bruits.  
Ext: No c/c/e. No femoral bruits.  
Skin: No stasis dermatitis, or xanthomas. left first toe ulcer 
~5mm diameter, no drainage or erythema.  
.  
Pulses:  
Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 1+ ___ 1+  
Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 1+ ___ 1+  
 
Pertinent Results:
___ 07:45PM BLOOD WBC-9.9 RBC-3.18* Hgb-8.2* Hct-25.1* 
MCV-79* MCH-25.9* MCHC-32.9 RDW-14.8 Plt ___
___ 07:45PM BLOOD Neuts-69.2 ___ Monos-4.8 Eos-1.8 
Baso-0.6
___ 07:45PM BLOOD Glucose-310* UreaN-20 Creat-1.1 Na-136 
K-5.4* Cl-98 HCO3-26 AnGap-17
___ 07:45PM BLOOD LD(LDH)-158 TotBili-0.4 Hapto-600*
___ 07:45PM BLOOD CK(CPK)-27 CK-MB-NotDone cTropnT-<0.01
___ 06:50AM BLOOD CK(CPK)-23* cTropnT-<0.01 
___ 06:50AM BLOOD proBNP-___*
___ 03:22PM BLOOD CK(CPK)-24* CK-MB-NotDone cTropnT-<0.01
___ 06:50AM BLOOD calTIBC-306 Ferritn-77 TRF-235
.
___ UCX: STAPHYLOCOCCUS, COAGULASE NEGATIVE.    
10,000-100,000 ORGANISMS/ML.. speciation and sensitivities 
pending
.
EKG demonstrated NSR ___, no STE/STD, with no significant change 
compared with prior dated ___  
.  
___ CXR: Cardiomegaly, mild interstitial congestion, and 
small bilateral pleural effusions.  
.  
___ Echo: The left atrium is mildly dilated. Left 
ventricular wall thicknesses are normal. The left ventricular 
cavity is mildly dilated. Due to suboptimal technical quality, a 
focal wall motion abnormality cannot be fully excluded. Overall 
left ventricular systolic function is normal (LVEF>55%). Right 
ventricular chamber size and free wall motion are normal. The 
aortic valve leaflets (3) appear structurally normal with good 
leaflet excursion. Trace aortic regurgitation is seen. The 
mitral valve leaflets are mildly thickened. Mild (1+) mitral 
regurgitation is seen. There is mild pulmonary artery systolic 
hypertension. There is no pericardial effusion. 
.
No vegetation seen but cannot definitively exclude. 
.
Compared with the prior study (images reviewed) of ___, 
there is no definite change.  
 
Brief Hospital Course:
The patient is a ___ year-old female with PMH significant for CAD 
s/p CABG in ___ (EF=50-55%), IDDM, hyperlipidemia, and HTN who 
presents with new DOE and persistent low-grade fever.  
.  
#. CAD - The patient ruled out for acute MI with negative 
cardiac enzymes x 3 and no evidence of ischemia on EKG. The 
patient had an echo inhouse to evaluate for presence of new wall 
motion abnormality as new CHF could have been secondary to 
recent MI; however, wall motion overall appeared unchanged from 
prior. (Note: new ___ could not be excluded on echo due to poor 
windows.) The patient was continued on medical management with 
aspirin, plavix, BB, statin, and imdur with no acute issues.  
.  
#. Pump/ acute diastolic CHF - The patient had no evidence of 
CHF at recent outpatient cardiology visit ___, but now presented 
with clinical symptoms and radiographic evidence of CHF. BNP was 
elevated at 2200 (no baseline for comparison). Echo was 
consistent with mild diastolic failure with LVEF 60%. Etiology 
of CHF was unclear, but high output failure was considered in 
the setting of fever and anemia. Silient ischemia was felt to be 
unlikely as there were no new focal WMA on echo (however, this 
could not be fully excluded due to poor windows). The patient 
responded well to diuresis with IV lasix with resolution of SOB 
and ___ edema. Home dose of lasix 40mg po daily was started prior 
to discharge. She was continued on ACE, BB, and CCB for 
afterload reduction. The patient was discharged on mild 2000cc 
fluid restriction, and was advised to ___ with her 
cardiologist for further management.
.  
#. Rhythm - NSR on telemetry. The patient was continued on home 
BB. 
.  
#. HTN - The patient was continued on home regimen of ACE, BB, 
norvasc, and lasix. Lisinopril dose was decreased from 30mg 
daily to 20mg daily for hyperkalemia. 
.  
#. Hyperlipidemia - Lipid panel showed: Tchol-116, ___, 
HDL-20, LDL-59 in ___. 
The patient was continued on home regimen of zetia and 
atorvastatin.  
.  
# Fevers - The patient reported history of low-grade fevers to 
100.8 for approx 2 weeks. There was no localizing signs or 
symptoms of infection on exam, except known UTI that was being 
treated with an extended course of bactrim. Etiology of fever 
was felt to be secondary to inadequately treated UTI ___ 
coag neg staph here, outpatient UCx on ___ with 8K gram pos 
colonies with no speciation or sensitivities at that time) 
versus drug fever in response to Bactrim. Admission CBC was 
without leukocytosis or left shift, CXR was without obvious 
infiltrate. BCx were negative to date during admission. R foot 
films were negative for osteomyelitis (small superficial 
nonhealing ulcer on R great toe and elevated ESR/ CRP earlier in 
___. Other infectious sources include possible endocarditis 
given new murmur and elevated ESR and CRP on last admission; 
however, the patient did not consent to TEE (TTE negative for 
vegitation, but poor windows). ROS was negative for 
rheumatologic disease. The patient was switched to ciprofloxacin 
to complete a 7 day course for presumptive UTI - temperature 
curve decreased to < 100 after this switch. Speciation and 
sensitivities on urine culture were pending at the time of 
discharge, and may be followed up by the patient's PCP. The 
patient was advised to monitor fever curve after discharge.
.  
#. IDDM - The patient has a history of poorly controlled IDDM 
with recent HbA1c of 14.5% in ___. She was previously followed 
by ___, though not recently. The patient was seen by the 
___ inhouse. Insulin regimen was uptitrated with good 
effect - BS in the 100s prior to discharge. She was set-up for 
___ in ___ for further care. Neurontin was continued 
for neuropathic pain.  
.  
#. Anemia - The patient had evidence of a microcytic anemia with 
hct ___ during admission. Fe studies were consistent with iron 
deficiency, but likely has an element of AOCD given elevated ESR 
and CRP. Retic slightly elevated at 1.9%. There was no evidence 
of bleeding or hemolysis (guaiac negative on rectal exam in ED, 
no recent procedures, hemolysis labs negative). There is no 
family history of colon cancer, and the patient has not had a 
prior colonoscopy. The patient is still menstruating. She was 
started on iron supplementation inhouse and advised to have hct 
monitored as an outpatient. If ESR is still elevated and anemia 
persists in ___ weeks, rheumatologic evaluation may be 
considered. (Rheumatologic ROS negative as inpatient). 
Outpatient colonoscopy may be considered in the future.
.  
#. Hyperkalemia - The patient presented with peristent 
hyperkalemia (K 5.3-5.6) inhouse despite lasix and kayexalate. 
There were no EKG changes. Lisinopril dose was decreased to 20mg 
daily. Home lasix was continued. KCl supplementation was 
discontinued. 
.
#. The patient was discharged in good condition on ___ with 
cardiology and PCP ___ in place.
 
Medications on Admission:
1. Norvasc 10 mg a day.  
2. Aspirin 325 mg once daily.  
3. Plavix 75 mg once daily.  
4. Zetia 10 mg once daily.  
5. Lasix 40 mg once daily.  
6. Neurontin 300 mg three times a day.  
7. Imdur 30 mg daily.  
8. Zestril 30 mg daily.  
9. Lopressor 50 mg b.i.d.  
10. Sublingual nitroglycerin.  
11. Potassium 20 mEq.  
12. Zoloft 50 mg daily.  
 
Discharge Medications:
1. Aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  
2. Clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
3. Amlodipine 5 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).  

4. Ezetimibe 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  

5. Furosemide 40 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
6. Gabapentin 300 mg Capsule Sig: One (1) Capsule PO TID (3 
times a day).  
7. Isosorbide Mononitrate 30 mg Tablet Sustained Release 24 hr 
Sig: One (1) Tablet Sustained Release 24 hr PO DAILY (Daily).  
8. Lisinopril 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Disp:*30 Tablet(s)* Refills:*2*
9. Ciprofloxacin 500 mg Tablet Sig: One (1) Tablet PO Q12H 
(every 12 hours) for 5 days.
Disp:*10 Tablet(s)* Refills:*0*
10. Metoprolol Tartrate 50 mg Tablet Sig: One (1) Tablet PO BID 
(2 times a day).  
11. Nitroglycerin 0.3 mg Tablet, Sublingual Sig: One (1) tablet 
Sublingual Q5min PRN: please call ___ if chest pain is not 
releived after 3 tablets.  
12. Sertraline 50 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary:
Coronary Artery Disease
Diastolic heart failure  
Urinary tract infection

Secondary:
Dyslipidemia
Hypertension   
Left great toe ulcer
Depression

 
Discharge Condition:
Stable, afebrile, saturating well on room air

 
Discharge Instructions:
You were admitted with shortness of breath with exertion. An 
echocardiogram showed mild heart failure. Your shortness of 
breath improved throughout the hospital stay with diuretics. In 
addition, your fevers have resolved, and you should continue to 
take your antibiotic (ciprofloxacin) as prescribed for your UTI. 
If you continue to feel shortness of breath, fevers, or develop 
any new symptoms such as chest pain, headache, nausea, vomiting, 
severe back pain, or other concerning symptoms, please seek 
medical attention immediately. 

You have follow up appointments scheduled with your PCP, your 
cardiologist, and your endocrinologist at the ___. If you 
cannot keep these appointments, please call to reschedule. 
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=15521468-DS-16 | hadm_id=29561912

 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Bactrim / Nafcillin
 
Attending: ___.
 
Chief Complaint:
Hypotension, oliguria 
 
Major Surgical or Invasive Procedure:
Incision and Drainage Left Lower Extremity ___, 
___
Upper Endoscopy 

 
History of Present Illness:
___ with h/o CAD s/p 5v CABG, DM2, and HTN, admitted with L leg 
erythema, fever, and now with ___. Pt initially awoke on ___ 
with fevers to 102.5 and shaking chills, along with multiple 
episodes of nausea and nonbilious, nonbloody emesis. 
Significantly decreased po intake over the next ___ days as 
well. On ___, pt subsequently developed L foot swelling, 
erythema, and pain, along with a large blister on the medial 
aspect of her L foot. Over the course of three days, she took 3 
tabs of ibuprofen tid, unsure of dose. She denied orthostatic 
sx. Pt presented to the ED on ___ morning ___-- at that 
time, was febrile to 102.1 with rigors (was given ibuprofen and 
tylenol). She was started on zosyn/vancomycin for cellulitis and 
admitted to medicine. Creat at that time was 1.6. Since then, 
BCx have grown out coag + staph in ___ bottles.  
.  
After admission, pt progressively became more hypotensive, with 
diminishing urine output over the day yesterday. Was given 6L 
0.9NS on the floor, with BPs remaining in mid-80s systolic. She 
also developed new onset RUE weakness; MRI was negative for 
acute stroke. She was transferred to MICU last night, where she 
has remained febrile and hypotensive, and was started on 
dopamine. Pt currently being followed by podiatry and vascular 
surgery, who feel that this is acute charcot foot with overlying 
soft tissue infection.  
.  
Currently, pt c/o nausea and continued dry heaves. Denies 
dyspnea, orthostatic sx, or chest pain. Says she has been told 
about mild CKD in the past, but is unsure about her baseline 
creatinine. She has never been told about proteinuria in the 
past, and denies regular NSAID use (aside from acute use in past 
few days).  

 
Past Medical History:
PAST MEDICAL HISTORY:  ___ has got a number of medical 
problems stemming from hypertension and diabetes.  She has had 
diabetes for a long period of time and her most recent 
hemoglobin A1c level was notably elevated at 14%.  She has a 
history of coronary artery disease and had a CABG in ___.  She 
reportedly has an ejection fraction of 50 to 55%.  She has a 
history of hyperlipidemia and hypertension.  With respect to her 
bypass, she has had stents placed as well.  Her CABG was 
complicated by a sternal wound infection.  Her most recent echo 
was obtained on ___.  This reveals ejection fraction of 
greater than or equal to 55% with no evidence of endocarditis.  
She has never had a colonoscopy and she had her last mammogram 
___ years ago. She also has anemia and her most recent 
hematocrit was 30%.  She has an elevated platelet level greater 
than 500.
* CAD s/p 5v CABG in ___, with subsequent 4v CABG 6 months 
later  
* DM2, diagnosed in ___, complicated by retinopathy and 
neuropathy, poorly controlled  
* HTN  
* hyperlipidemia  
* anemia  

PAST SURGICAL HISTORY:  In ___ and ___, she had her coronary
artery bypass.  She has had three C-sections.

OB/GYN HISTORY:  She denies any history of pelvic infections. 
She denies any history of abnormal Pap smears, and her last was
obtained in ___.  She denies any complications of cesarean
section.
 
Social History:
___
Family History:
She reports her mother developed lung cancer, she was a smoker.  
She had a grandmother and an aunt who had breast cancer, 
grandmother was sick in her ___ and her aunt was in her ___.  
There is no other family history of cancer.
 
Physical Exam:
Vitals: T: 98.0 BP: 102/58 P: 69 R: 20 O2: 98% 4L NC  
General: Alert, oriented, no acute distress  
HEENT: Sclera anicteric, EOMI, MMM, oropharynx clear  
Neck: supple, JVP not elevated, no LAD  
Lungs: Clear to auscultation bilaterally, no wheezes, rales, 
ronchi  
CV: Regular rate and rhythm, normal S1 + S2. ___ holosystolic 
murmur loudest on left sternal border. no rubs, gallops  
Abdomen: Normoactive bowel sounds, obese, soft, non-tender, 
non-distended, no rebound tenderness or guarding, no 
organomegaly  
Ext: Warm, well perfused, 2+ DP on R, LLE wrapped in ACE 
bandage. Ankle ROM intact bilaterally. 1+ pitting edema 
bilateral lower extremities to knees with severe left foot 
edema.  
Skin: Warm 2cm x 2cm erythematous and purplish discoloration 
across the anterior aspect of the lower leg.  
Neuro: alert and oriented x 3, strength ___ in all extremities  

 
Pertinent Results:
LABS ON ADMISSION:
___ 12:05PM BLOOD WBC-10.5# RBC-4.46 Hgb-12.4 Hct-37.2 
MCV-84 MCH-27.9 MCHC-33.4 RDW-13.7 Plt ___
___ 12:05PM BLOOD Neuts-90.4* Lymphs-4.6* Monos-3.9 Eos-0.6 
Baso-0.6
___ 12:05PM BLOOD ___ PTT-24.9 ___
___ 12:05PM BLOOD ESR-114*
___ 12:05PM BLOOD Glucose-534* UreaN-39* Creat-1.6* Na-130* 
K-4.6 Cl-89* HCO3-28 AnGap-18
___ 03:30PM BLOOD ALT-25 AST-28 AlkPhos-120* TotBili-0.7
___ 07:16AM BLOOD Calcium-7.8* Phos-4.0# Mg-1.8
___ 03:30PM BLOOD Cortsol-28.3*
___ 12:13PM BLOOD Glucose-404* Lactate-2.6* K-4.4
___ 12:20PM BLOOD freeCa-0.96*

LABS ON TRANSFER FROM THE ICU:
___ 03:36AM BLOOD WBC-10.2 RBC-3.43* Hgb-9.6* Hct-28.2* 
MCV-82 MCH-27.9 MCHC-34.0 RDW-14.2 Plt ___
___ 03:36AM BLOOD Plt ___
___ 01:44PM BLOOD Glucose-117* UreaN-52* Creat-3.9* Na-130* 
K-4.1 Cl-100 HCO3-17* AnGap-17
___ 01:44PM BLOOD Calcium-6.9*
___ 12:20PM BLOOD Type-ART pH-7.35
___ 12:20PM BLOOD Lactate-0.8
___ 12:20PM BLOOD freeCa-0.96*

LABS ON SECOND TRANSFER FROM ICU:

LABS ON DISCHARGE:

MICROBIOLOGY:
___ URINE URINE CULTURE-FINAL INPATIENT 
___ MRSA SCREEN MRSA SCREEN-PENDING INPATIENT 
___ BLOOD CULTURE Blood Culture, Routine-PENDING 
INPATIENT 
___ BLOOD CULTURE Blood Culture, Routine-FINAL {STAPH 
AUREUS COAG +}; Aerobic Bottle Gram Stain-FINAL; Anaerobic 
Bottle Gram Stain-FINAL INPATIENT 
___ BLOOD CULTURE Blood Culture, Routine-FINAL {STAPH 
AUREUS COAG +}; Aerobic Bottle Gram Stain-FINAL; Anaerobic 
Bottle Gram Stain-FINAL EMERGENCY WARD 

IMAGING:
 
___ L foot x-ray:  
1. Findings concerning for possible osteomyelitis superimposed 
on an evolving Charcot's joint, although no radiographic 
evidence of ulcer. Extensive osseous destruction and lucencies 
involving the medial and mid cuneiforms, second and third 
metatarsal bases, and navicular bone. While findings could in 
part relate to an evolving Charcot's joint, new since ___, 
they are in conjunction with overlying soft tissue gas and 
swelling, making superimposed osteomyelitis of concern. 
Recommend clinical correlation for soft tissue  
defect/ulcer and further evaluation with nuclear medicine study 
or MRI.  
2. Gas noted in anterior ankle. Given known leg cellulitis, 
proximal extent not evaluated.  

___ MRI/MRA Head: No signs of infarct.  

___ CXR:  
Comparison is made to the prior study from ___. The heart 
is enlarged. There is atelectasis at the left lung base with a 
small left pleural effusion. This is status post median 
sternotomy. Right lung is relatively clear.  

___ Renal ultrasound: No evidence of hydronephrosis.  

___ TTE:  
The left atrium is mildly dilated. Left ventricular wall 
thickness, cavity size and regional/global systolic function are 
normal (LVEF >55%). Right ventricular chamber size and free wall 
motion are normal. The diameters of aorta at the sinus, 
ascending and arch levels are normal. The aortic valve leaflets 
(3) appear structurally normal with good leaflet excursion and 
no aortic regurgitation. The mitral valve leaflets are mildly 
thickened. Mild (1+) mitral regurgitation is seen. There is mild 
pulmonary artery systolic hypertension. There is no pericardial 
effusion.  
IMPRESSION: Mild tricuspid regurgitation. Normal biventricular 
cavity sizes with preserved global and regional biventricular 
systolic function. Mild pulmonary artery systolic hypertension.  

Compared with the prior report (images unavailable for review) 
of ___, the findings are similar.  

 
Brief Hospital Course:
___ year old F with hx of CAD, DM, HTN presented with left lower 
extremity pain and erythma secondary to acute charcot foot with 
overlying cellulitis. On floor patient developed hypotension and 
oliguria despite 6 L NS IVF due to MSSA sepsis.  She improved 
and was sent out to the floor where she continued treatment for 
MSSA bacteremia and L Charcot foot, cellulitis and osteomyelitis 
until she developed a GI bleed from a Dieulafoy lesion.  After 
endoscopy with endoclips and cautery, she was stabilized and 
sent back to the floor for continued management.  After 
returning to the floor her course was then complicated by 
another debridement and then renal failure due to AIN from her 
nafcillin.  
.
# Left Charcot foot with osteomyelitis and overlying cellulitis: 
Patient presented with left lower extremity pain and erythema.  
She was seen by podiatry and vascular surgery who felt this was 
consistent with an acute Charcot foot.  She then became 
hypotensive and oliguric requiring MICU admission where she was 
found to be septic with MSSA. Her foot was the presumed source 
and a CT of her leg showed several gas pockets within the foot 
and ankle. Patient underwent I&D on ___ with swab and tissue 
cultures showing MSSA.  Infectious disease was consulted and 
recommended at least a 6 week course of nafcillin, however after 
her final debridement cultures were growing enterobacter and 
klebsiella, and she developed AIN her antibiotic regimen was 
changed to ciprofloxacin and vancomycin.  She will need 6 weeks 
of vancomycin from the date of her last debridement on ___, 
and ___ weeks of ciprofloxacin from ___, this course will be 
outlined during her ID appointment in ___.  She will need 
weekly labs that include: cbc, diff, bun, cr, lfts, esr, 
crp,vancomycin trough and  have ALL THE LABS faxed to the 
infectious disease R.Ns. at ___.  
.
# Dieulafoy lesion: She had a hematocrit drop while on the floor 
and was found to have melena. She was transferred to the ICU for 
GI bleed and required 12 units of blood in less than 48 hours. 
She had a few EGDs on ___ and on ___ showing clot in stomach 
from a Dieulafoy lesion. The gastroenterologists were unable to 
intervene on first two endoscopies but able to cauterize and 
place clips on the third endoscopy which was performed with 
intubation in the OR for direct visualization. Her hematocrit 
then stabilized, and she was started on a PPI, she had no 
further evidence of GI bleeding during her stay, and GI felt 
that it was safe for her to be started on anticoagulation.  
.
# MSSA bacteremia: The source of her bacteremia was likely her 
left foot given same speciation and sensitivites. There were no 
signs of endocarditis on transthoracic echocardiogram but the 
study was deemed suboptimal.  The patient declined a 
transesophageal echocardiogram but this was felt to not be 
necessary as she will already require a 6 week course of IV 
antibotic therapy.  Due to her new allergy to nafcillin as a 
result of the AIN, her antibiotics were changed to 
vancomycin/ciprofloxacin as above for the bacteremia.   
.
# Left upper extremity deep venous thrombus: She was found to 
have a DVT surrounding her PICC in her left arm.  She was 
initially started on a heparin drip as a bridge to coumadin, the 
left arm PICC was removed and PICC was placed in her right arm.  
She will complete a three month course of coumadin, if she 
becomes subtherapeutic on coumadin there is no indication for 
bridging with heparin, so she can be continued on coumadin until 
her INR is back in the therapeutic range.
.
# Acute renal failure: Patient developed oliguria very soon 
after admission, and urine sediment showed muddy brown casts 
consistent with ATN.  The etiology of her ATN was likely 
hypotension leading to hypoperfusion while she was septic from 
MSSA. Her creatinine steadily improved and returned to near her 
baseline.  Then around ___ her creatinine started to increase 
again, it peaked at 2.0 and renal was consulted.  Examination of 
the urine showed white cells and cellular casts, renal felt that 
this was consistent with AIN, most likely from Nafcillin.  They 
also felt that there was a component of congestive heart failure 
that was also contributing.  Her antibiotics were changed to 
vancomycin and she was started on more aggressive diuresis of 
lasix 80mg IV twice a day.  Given the large amount of excess 
fluid, she will currently be continued on the same dose of IV 
lasix.  If her creatinine increases again, or diuresis starts to 
slow, she can then be transitioned back to an oral dose, she was 
admitted on 40mg po daily.  Creatinine at the time of discharge 
was 1.2, her renal function will need to be continually 
monitored as her vancomycin dosing may change as her renal 
function changes.  We held her valsartan in the setting of her 
renal failure and also while she was getting IV lasix, if she 
needs better blood pressure control can restart valsartan 80mg 
daily if her creatinine is back to her baseline of 1.0.
.  
# RUE weakness: She acutely developed difficulty raising her 
right arm on ___ but had a negative head MRI after code stroke 
was called. Neurology felt this was a brachial plexus 
neuropathy, likely pressure related from non-invasive 
measurements done in the ED. MRI of C-spine showed severe canal 
and foraminal narrowing at C5-6 and C6-7 with cord deformity but 
no signs of abscess. Spine was consulted who recommended a CT 
scan of her C-spine for better evaluation but felt this was 
non-critical.  She should follow-up with the spine clinic after 
discharge and her rehabilitation stay.
.  
# Hypocalcemia with hyperphosphatemia: In the setting of acute 
renal failure, she had a low ionized calcium and 
hyperphosphatemia. Sevelamer was started with meals to help 
correct this imbalance until her renal function improved.  Once 
her renal function improved, the sevelamer was discontinued.
.
# CAD: She had no complaints of chest pain or SOB throughout her 
stay.  She was continued on ASA, plavix and statin initially 
until she developed a GI bleed.  At that time her 
anticoagulation was stopped, and not restarted until a week 
after final EGD.  She was resumed on aspirin and statin but her 
plavix continued to be held given her need for warfarin.  
.
# DM: She was continued on ISS with Lantus.  She needed 
continual uptitration of her lantus dose for improved glycemic 
control.  Her humalog sliding scale from the hospital was 
included in her paperwork.  
.
# Acute on chronic diastolic congestive heart failure: Her EF 
>55% on transthoracic echocardiogram. She was initially 
euvolemic but developed volume overload from IV fluids and blood 
products. She continues to be on aggressive diuresis with lasix 
given her total volume overload, and fact that her renal 
function improved with diuresis she was discharged on 80mg IV 
BID, and will likely need up to a week more of diuresis with IV 
lasix, we would recommend continuing as long as her creatinine 
remains stable.  We held her valsartan in the setting of her 
renal failure and also while she was getting IV lasix, if she 
needs better blood pressure control can restart valsartan 80mg 
daily if her creatinine is back to her baseline of 1.0.  
.
# Dyslipidemia: She was continued on atorvastatin. 
.
# Thyroid nodule: Incidental finding on C-spine MR, elevated TSH 
with normal T4 consistent with sick euthyroid, she will need 
further outpatient follow up of the thyroid nodule after rehab.  
 
  
 
Medications on Admission:
amlodipine 10, atorvastatin 80, plavix 75 mg, furosemide 40 mg 
daily, gabapentin 300 mg po tid, imdur 30 mg po daily, 
metoprolol 100 mg po bid, valsartan 80 mg daily, ASA 325, Fe 
sulfate, MVI, sertraline 100mg, ativan 0.5mg QID:PRN
 
Discharge Medications:
 

1. Miconazole Nitrate 2 % Powder Sig: One (1) Appl Topical TID 
(3 times a day) as needed for rash.  
2. Metoprolol Tartrate 50 mg Tablet Sig: One (1) Tablet PO BID 
(2 times a day).  
3. Atorvastatin 80 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
4. Amlodipine 5 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).  

5. Lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO twice a day as 
needed for severe anxiety.  
6. Isosorbide Mononitrate 30 mg Tablet Sustained Release 24 hr 
Sig: One (1) Tablet Sustained Release 24 hr PO DAILY (Daily).  
7. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 
times a day).  
8. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day) as needed for constipation.  
9. Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable 
PO DAILY (Daily).  
10. Sucralfate 1 gram Tablet Sig: One (1) Tablet PO QID (4 times 
a day).  
11. Sertraline 50 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
12. Insulin Glargine 100 unit/mL Solution Sig: Twenty (20) units 
Subcutaneous at bedtime.  
13. Hydromorphone 2 mg Tablet Sig: ___ mg PO Q6H (every 6 hours) 
as needed for pain: hold for sedation, RR<12.  
14. Gabapentin 300 mg Capsule Sig: One (1) Capsule PO every 
eight (8) hours.  
15. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One 
(1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours).  
16. Ciprofloxacin 500 mg Tablet Sig: One (1) Tablet PO Q12H 
(every 12 hours).  
17. Warfarin 5 mg Tablet Sig: One (1) Tablet PO Once Daily at 4 
___.  
18. Heparin, Porcine (PF) 10 unit/mL Syringe Sig: Two (2) ML 
Intravenous PRN (as needed) as needed for line flush.  
19. Ondansetron 8 mg Tablet, Rapid Dissolve Sig: One (1) Tablet, 
Rapid Dissolve PO every eight (8) hours as needed for nausea.  
20. Vancomycin in D5W 1 gram/200 mL Piggyback Sig: One (1)  
Intravenous Q 24H (Every 24 Hours).  
21. Sodium Chloride 0.9%  Flush 10 mL IV PRN line flush 
PICC, non-heparin dependent: Flush with 10 mL Normal Saline 
daily and PRN per lumen. 
22. Furosemide 80 mg IV BID 
Hold for SBP<100
 
23. Insulin Lispro 100 unit/mL Solution Sig: Sliding Scale  As 
directed  Subcutaneous ACHS: Please follow attached sliding 
scale.  
24. Multivitamin     Tablet Sig: One (1) Tablet PO once a day.  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Primary:
MSSA bacteremia
Left Charcot foot
Left lower leg cellulitis
Acute renal failure
Dieulafoy Lesion causing an upper GI bleed 

Secondary:
Diabetes mellitus 
CAD s/p CABG

 
Discharge Condition:
Mental Status: Confused - sometimes, usually oriented x 3, but 
has difficulty with attention
Level of Consciousness: Alert and interactive usually, will at 
times be very sleepy but very easily arousable.  
Activity Status: Bedbound, currently requires assistance to get 
out into the chair 

 
Discharge Instructions:
You were admitted to the hospital for pain in your left foot. 
Your blood pressure dropped, and you were found to have a 
bacteria in your blood stream likely from your infected foot. 
You had a deep infection in your left foot and lower leg that 
required clean out in the OR.  You improved on antibiotics.  
During your stay you also had a bleeding artery in your stomach, 
which required a stay in the ICU and an upper endoscopy done by 
gastroenterology with clipping of the artery.  Also, during your 
stay you were found to have an allergic reaction in your kidneys 
to one of the antibioitics, and your kidney function improved 
with removal of the antibiotics.  You will need close follow up 
with podiatry after you leave for monitoring of the healing of 
your left leg.  Also, since your hospital stay was very 
prolonged and complicated you will need a lot of rehabilitation 
to get your strength back.  
.
We made multiple changes to your medication regimen during your 
stay:
1. STARTED Coumadin 5mg daily for a left arm DVT
2. STARTED Sucralfate four times per day 
3. STARTED Dilaudid ___ every 6 hours as needed for pain 
4. STARTED Pantoprazole 40mg daily 
5. STARTED Ciprofloxacin 500mg twice a day for ___ weeks from 
___, ID will address stopping this medication during your 
appt
6. STARTED Vancomycin 1g every 24 hours for 6 weeks from ___
7. DECREASED Metoprolol to 50mg twice a day 
8. STOPPED Valsartan due to your kidney failure
9. STOPPED Plavix when you had bleeding from your stomach, 
follow up with your PCP and cardiologist about restarting this 
medication 
10. STOPPED Lasix 40mg daily by mouth 
11. STARTED Lasix 80mg IV twice a day 
12. DECREASED home ativan dose due to somnolence to 0.5mg twice 
a day as need for anxiety 
13. ADDED dilaudid ___ every ___ hours as needed for pain 
Please continue to take all other medications as previously 
prescribed
 
Followup Instructions:
___
